CD_NAME,NCBI_NAME,GeneID,Synonyms,map_location,description,Other_designations
CD1a,CD1A,909,CD1 FCB6 HTA1 R4 T6,1q23.1,CD1a molecule,"T-cell surface glycoprotein CD1a; CD1A antigen, a polypeptide; T-cell surface antigen T6/Leu-6; cluster of differentiation 1 A; cortical thymocyte antigen CD1A; differentiation antigen CD1-alpha-3; epidermal dendritic cell marker CD1a; hTa1 thymocyte antigen"
CD1b,CD1B,910,CD1 CD1A R1,1q23.1,CD1b molecule,"T-cell surface glycoprotein CD1b; CD1B antigen, b polypeptide; cortical thymocyte antigen CD1B; differentiation antigen CD1-alpha-3"
CD1c,CD1C,911,BDCA1 CD1 CD1A R7,1q23.1,CD1c molecule,"T-cell surface glycoprotein CD1c; CD1C antigen, c polypeptide; cortical thymocyte antigen CD1C; differentiation antigen CD1-alpha-3"
CD1d,CD1D,912,CD1A R3 R3G1,1q23.1,CD1d molecule,"antigen-presenting glycoprotein CD1d; CD1D antigen, d polypeptide; HMC class I antigen-like glycoprotein CD1D; T-cell surface glycoprotein CD1d; differentiation antigen CD1-alpha-3; thymocyte antigen CD1D"
CD1e,CD1E,913,CD1A R2,1q23.1,CD1e molecule,"T-cell surface glycoprotein CD1e, membrane-associated; CD1E antigen, e polypeptide; R2G1; differentiation antigen CD1-alpha-3; hCD1e; leukocyte differentiation antigen; thymocyte antigen CD1E"
CD2,CD2,914,LFA-2 SRBC T11,1p13.1,CD2 molecule,"T-cell surface antigen CD2; CD2 antigen (p50), sheep red blood cell receptor; LFA-3 receptor; T-cell surface antigen T11/Leu-5; erythrocyte receptor; lymphocyte-function antigen-2; rosette receptor"
CD3d,CD3D,915,CD3-DELTA IMD19 T3D,11q23.3,CD3d molecule,"T-cell surface glycoprotein CD3 delta chain; CD3 antigen, delta subunit; CD3 delta; CD3d antigen, delta polypeptide (TiT3 complex); CD3d molecule, delta (CD3-TCR complex); OKT3, delta chain; T-cell receptor T3 delta chain"
CD3e,CD3E,916,IMD18 T3E TCRE,11q23.3,CD3e molecule,"T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; CD3e antigen, epsilon polypeptide (TiT3 complex); CD3e molecule, epsilon (CD3-TCR complex); T-cell antigen receptor complex, epsilon subunit of T3; T-cell surface antigen T3/Leu-4 epsilon chain"
CD3g,CD3G,917,CD3-GAMMA IMD17 T3G,11q23.3,CD3g molecule,"T-cell surface glycoprotein CD3 gamma chain; CD3g antigen, gamma polypeptide (TiT3 complex); CD3g molecule, epsilon (CD3-TCR complex); CD3g molecule, gamma (CD3-TCR complex); T-cell antigen receptor complex, gamma subunit of T3; T-cell receptor T3 gamma chain"
CD4,CD4,920,CD4mut,12p13.31,CD4 molecule,T-cell surface glycoprotein CD4; CD4 antigen (p55); CD4 receptor; T-cell surface antigen T4/Leu-3
CD5,CD5,921,LEU1 T1,11q12.2,CD5 molecule,T-cell surface glycoprotein CD5; CD5 antigen (p56-62); lymphocyte antigen T1/Leu-1
CD6,CD6,923,TP120,11q12.2,CD6 molecule,T-cell differentiation antigen CD6; CD6 antigen; T12
CD7,CD7,924,GP40 LEU-9 TP41 Tp40,17q25.3,CD7 molecule,T-cell antigen CD7; CD7 antigen (p41); T-cell leukemia antigen; T-cell surface antigen Leu-9; p41 protein
CD8a,CD8A,925,CD8 Leu2 MAL p32,2p11.2,CD8a molecule,"T-cell surface glycoprotein CD8 alpha chain; CD8 antigen, alpha polypeptide (p32); Leu2 T-lymphocyte antigen; OKT8 T-cell antigen; T cell co-receptor; T-cell antigen Leu2; T-lymphocyte differentiation antigen T8/Leu-2; T8 T-cell antigen"
CD8b,CD8B,926,CD8B1 LEU2 LY3 LYT3 P37,2p11.2,CD8b molecule,"T-cell surface glycoprotein CD8 beta chain; CD8 antigen, beta polypeptide 1 (p37); T lymphocyte surface glycoprotein beta chain"
CD9,CD9,928,BTCC-1 DRAP-27 MIC3 MRP-1 TSPAN-29 TSPAN29,12p13.31,CD9 molecule,CD9 antigen; 5H9 antigen; BA-2/p24 antigen; CD9 antigen (p24); antigen CD9; cell growth-inhibiting gene 2 protein; leukocyte antigen MIC3; motility related protein-1; tetraspanin-29
CD10,MME,4311,CALLA CD10 CMT2T NEP SCA43 SFE,3q25.2,membrane metalloendopeptidase,"neprilysin; atriopeptidase; common acute lymphocytic leukemia antigen; membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10); membrane metallo-endopeptidase variant 1; membrane metallo-endopeptidase variant 2; neprilysin-390; neprilysin-411; neutral endopeptidase 24.11; skin fibroblast elastase"
CD11a,ITGAL,3683,CD11A LFA-1 LFA1A,16p11.2,integrin subunit alpha L,"integrin alpha-L; CD11 antigen-like family member A; LFA-1 alpha; LFA-1A; antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide; integrin gene promoter; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); leukocyte adhesion glycoprotein LFA-1 alpha chain; leukocyte function-associated molecule 1 alpha chain; lymphocyte function-associated antigen 1, alpha polypeptide"
CD11b,ITGAM,3684,CD11B CR3A MAC-1 MAC1A MO1A SLEB6,16p11.2,integrin subunit alpha M,"integrin alpha-M; CD11 antigen-like family member B; CR-3 alpha chain; antigen CD11b (p170); cell surface glycoprotein MAC-1 subunit alpha; complement component 3 receptor 3 subunit; integrin, alpha M (complement component 3 receptor 3 subunit); leukocyte adhesion receptor MO1; macrophage antigen alpha polypeptide; neutrophil adherence receptor alpha-M subunit"
CD11c,ITGAX,3687,CD11C SLEB6,16p11.2,integrin subunit alpha X,"integrin alpha-X; CD11 antigen-like family member C; complement component 3 receptor 4 subunit; integrin alpha X; integrin, alpha X (antigen CD11C (p150), alpha polypeptide); integrin, alpha X (complement component 3 receptor 4 subunit); leu M5, alpha subunit; leukocyte adhesion glycoprotein p150,95 alpha chain; leukocyte adhesion receptor p150,95; leukocyte surface antigen p150,95, alpha subunit; myeloid membrane antigen, alpha subunit; p150 95 integrin alpha chain"
CD11d,ITGAD,3681,ADB2 CD11D,16p11.2,integrin subunit alpha D,integrin alpha-D; CD11 antigen-like family member D; beta-2 integrin alphaD subunit; leukointegrin alpha D
CD13,ANPEP,290,APN CD13 GP150 LAP1 P150 PEPN,15q26.1,"alanyl aminopeptidase, membrane",aminopeptidase N; AP-M; AP-N; alanyl (membrane) aminopeptidase; aminopeptidase M; hAPN; membrane alanyl aminopeptidase; microsomal aminopeptidase; myeloid plasma membrane glycoprotein CD13
CD14,CD14,929,"-",5q31.3,CD14 molecule,monocyte differentiation antigen CD14; myeloid cell-specific leucine-rich glycoprotein
CD15,FUT4,2526,CD15 ELFT FCT3A FUC-TIV FUTIV LeX SSEA-1,11q21,fucosyltransferase 4,"alpha-(1,3)-fucosyltransferase 4; ELAM ligand fucosyltransferase; ELAM-1 ligand fucosyltransferase; Lewis X; alpha (1,3) fucosyltransferase, myeloid-specific; fucT-IV; fucosyltransferase IV; galactoside 3-L-fucosyltransferase; stage-specific embryonic antigen 1"
CD16a,FCGR3A,2214,CD16 CD16A FCG3 FCGR3 FCGRIII FCR-10 FCRIII FCRIIIA IGFR3 IMD20,1q23.3,Fc fragment of IgG receptor IIIa,"low affinity immunoglobulin gamma Fc region receptor III-A; CD16a antigen; Fc fragment of IgG low affinity IIIa receptor; Fc fragment of IgG, low affinity III, receptor for (CD16); Fc fragment of IgG, low affinity IIIa, receptor (CD16a); Fc gamma receptor III-A; Fc gamma receptor IIIa; Fc-gamma RIII-alpha; Fc-gamma RIIIa; Fc-gamma receptor III-2 (CD 16); Fc-gamma receptor IIIb (CD16); FcgammaRIIIA; fc-gamma RIII; igG Fc receptor III-2; immunoglobulin G Fc receptor III; neutrophil-specific antigen NA"
CD16b,FCGR3B,2215,CD16 CD16b FCG3 FCGR3 FCR-10 FCRIII FCRIIIb,1q23.3,Fc fragment of IgG receptor IIIb,"low affinity immunoglobulin gamma Fc region receptor III-B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); Fc gamma receptor IIIb; Fc-gamma receptor IIIb (CD 16); fc-gamma RIII-beta; fc-gamma RIIIb; igG Fc receptor III-1"
CD17,"-",-,-,-,-,-
CD18,ITGB2,3689,CD18 LAD LCAMB LFA-1 MAC-1 MF17 MFI7,21q22.3,integrin subunit beta 2,"integrin beta-2; cell surface adhesion glycoprotein (LFA-1/CR3/P150,959 beta subunit precursor); complement component 3 receptor 3 and 4 subunit; complement receptor C3 beta-subunit; integrin beta chain, beta 2; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); leukocyte cell adhesion molecule CD18; leukocyte-associated antigens CD18/11A, CD18/11B, CD18/11C"
CD19,CD19,930,B4 CVID3,16p11.2,CD19 molecule,B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; T-cell surface antigen Leu-12; differentiation antigen CD19
CD20,MS4A1,931,B1 Bp35 CD20 CVID5 LEU-16 MS4A2 S7,11q12.2,membrane spanning 4-domains A1,"B-lymphocyte antigen CD20; B-lymphocyte cell-surface antigen B1; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; membrane-spanning 4-domains, subfamily A, member 1"
CD21,CR2,1380,C3DR CD21 CR CVID7 SLEB9,1q32.2,complement C3d receptor 2,complement receptor type 2; EBV receptor; complement component (3d/Epstein Barr virus) receptor 2; complement component 3d receptor 2
CD22,CD22,933,SIGLEC-2 SIGLEC2,19q13.12,CD22 molecule,B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; sialic acid-binding Ig-like lectin 2
CD23,FCER2,2208,BLAST-2 CD23 CD23A CLEC4J FCE2 IGEBF,19p13.2,Fc fragment of IgE receptor II,"low affinity immunoglobulin epsilon Fc receptor; C-type lectin domain family 4, member J; CD23 antigen; Fc epsilon receptor II; Fc fragment of IgE, low affinity II, receptor for (CD23); fc-epsilon-RII; immunoglobulin E-binding factor; immunoglobulin epsilon-chain; lymphocyte IgE receptor"
CD24,CD24,100133941,CD24A,6q21,CD24 molecule,signal transducer CD24; CD24 antigen (small cell lung carcinoma cluster 4 antigen)
CD25,IL2RA,3559,CD25 IDDM10 IL2R IMD41 TCGFR p55,10p15.1,interleukin 2 receptor subunit alpha,"interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2R subunit alpha; TAC antigen; interleukin 2 receptor, alpha"
CD26,DPP4,1803,ADABP ADCP2 CD26 DPPIV TP103,2q24.2,dipeptidyl peptidase 4,"dipeptidyl peptidase 4; ADCP-2; DPP IV; T-cell activation antigen CD26; adenosine deaminase complexing protein 2; dipeptidyl peptidase IV; dipeptidylpeptidase 4; dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2)"
CD27,CD27,939,S152 S152. LPFS2 T14 TNFRSF7 Tp55,12p13.31,CD27 molecule,"CD27 antigen; CD27L receptor; T cell activation antigen S152; T-cell activation antigen CD27; tumor necrosis factor receptor superfamily, member 7"
CD28,CD28,940,Tp44,2q33.2,CD28 molecule,T-cell-specific surface glycoprotein CD28; CD28 antigen
CD29,ITGB1,3688,CD29 FNRB GPIIA MDF2 MSK12 VLA-BETA VLAB,10p11.22,integrin subunit beta 1,"integrin beta-1; glycoprotein IIa; integrin VLA-4 beta subunit; integrin beta 1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); very late activation protein, beta polypeptide"
CD30,TNFRSF8,943,CD30 D1S166E Ki-1,1p36.22,TNF receptor superfamily member 8,tumor necrosis factor receptor superfamily member 8; CD30L receptor; Ki-1 antigen; cytokine receptor CD30; lymphocyte activation antigen CD30
CD31,PECAM1,5175,CD31 CD31/EndoCAM GPIIA' PECA1 PECAM-1 endoCAM,17q23.3,platelet and endothelial cell adhesion molecule 1,platelet endothelial cell adhesion molecule; CD31 antigen; platelet endothelial cell adhesion molecule-1
CD33,CD33,945,SIGLEC-3 SIGLEC3 p67,19q13.41,CD33 molecule,myeloid cell surface antigen CD33; CD33 antigen (gp67); CD33 molecule transcript; gp67; sialic acid-binding Ig-like lectin 3
CD34,CD34,947,"-",1q32.2,CD34 molecule,hematopoietic progenitor cell antigen CD34; CD34 antigen
CD35,CR1,1378,C3BR C4BR CD35 KN,1q32.2,complement C3b/C4b receptor 1 (Knops blood group),complement receptor type 1; C3-binding protein; C3b/C4b receptor; CD35 antigen; Knops blood group antigen; complement component (3b/4b) receptor 1 (Knops blood group)
CD36,CD36,948,BDPLT10 CHDS7 FAT GP3B GP4 GPIV PASIV SCARB3,7q21.11,CD36 molecule,"platelet glycoprotein 4; CD36 antigen (collagen type I receptor, thrombospondin receptor); CD36 molecule (thrombospondin receptor); GPIIIB; PAS IV; PAS-4 protein; cluster determinant 36; fatty acid translocase; glycoprotein IIIb; leukocyte differentiation antigen CD36; platelet glycoprotein IV; scavenger receptor class B, member 3"
CD37,CD37,951,GP52-40 TSPAN26,19q13.33,CD37 molecule,leukocyte antigen CD37; cell differentiation antigen 37; leukocyte surface antigen CD37; tetraspanin-26; tspan-26
CD38,CD38,952,ADPRC 1 ADPRC1,4p15.32,CD38 molecule,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; 2'-phospho-ADP-ribosyl cyclase; 2'-phospho-cyclic-ADP-ribose transferase; ADP-ribosyl cyclase 1; CD38 antigen (p45); NAD(+) nucleosidase; cluster of differentiation 38; cyclic ADP-ribose hydrolase 1; ecto-nicotinamide adenine dinucleotide glycohydrolase
CD39,ENTPD1,953,ATPDase CD39 NTPDase-1 SPG64,10q24.1,ectonucleoside triphosphate diphosphohydrolase 1,ectonucleoside triphosphate diphosphohydrolase 1; CD39 antigen; ecto-ATP diphosphohydrolase 1; ecto-ATPDase 1; ecto-ATPase 1; ecto-apyrase; lymphoid cell activation antigen
CD40,CD40,958,Bp50 CDW40 TNFRSF5 p50,20q13.12,CD40 molecule,"tumor necrosis factor receptor superfamily member 5; B cell surface antigen CD40; B cell-associated molecule; CD40 molecule, TNF receptor superfamily member 5; CD40L receptor"
CD41,ITGA2B,3674,BDPLT16 BDPLT2 CD41 CD41B GP2B GPIIb GT GTA HPA3 PPP1R93,17q21.31,integrin subunit alpha 2b,"integrin alpha-IIb; GPalpha IIb; alphaIIb protein; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); platelet fibrinogen receptor, alpha subunit; platelet glycoprotein IIb of IIb/IIIa complex; platelet membrane glycoprotein IIb; platelet-specific antigen BAK; protein phosphatase 1, regulatory subunit 93"
CD42a,GP9,2815,CD42a GPIX,3q21.3,glycoprotein IX platelet,platelet glycoprotein IX; glycoprotein 9
CD42b,GP1BA,2811,BDPLT1 BDPLT3 BSS CD42B CD42b-alpha DBPLT3 GP1B GPIbA GPIbalpha VWDP,17p13.2,glycoprotein Ib platelet alpha subunit,"platelet glycoprotein Ib alpha chain; GP-Ib alpha; antigen CD42b-alpha; glycoprotein Ib (platelet), alpha polypeptide; mutant platelet membrane glycoprotein Ib-alpha; platelet membrane glycoprotein 1b-alpha subunit; platelet membrane glycoprotein Ib-alpha"
CD42c,GP1BB,2812,BDPLT1 BS CD42C GPIBB GPIbbeta,22q11.21,glycoprotein Ib platelet beta subunit,"platelet glycoprotein Ib beta chain; GP-Ib beta; antigen CD42b-beta; glycoprotein Ib (platelet), beta polypeptide; nuclear localization signal deleted in velocardiofacial syndrome; platelet membrane glycoprotein Ib beta; truncated platelet membrane glycoprotein Ib beta"
CD42d,GP5,2814,CD42d GPV,3q29,glycoprotein V platelet,platelet glycoprotein V; glycoprotein 5
CD43,SPN,6693,CD43 GALGP GPL115 LSN,16p11.2,sialophorin,"leukosialin; galactoglycoprotein; leukocyte sialoglycoprotein; sialophorin (gpL115, leukosialin, CD43)"
CD44,CD44,960,CDW44 CSPG8 ECMR-III HCELL HUTCH-I IN LHR MC56 MDU2 MDU3 MIC4 Pgp1,11p13,CD44 molecule (Indian blood group),CD44 antigen; GP90 lymphocyte homing/adhesion receptor; Hermes antigen; cell surface glycoprotein CD44; chondroitin sulfate proteoglycan 8; epican; extracellular matrix receptor III; hematopoietic cell E- and L-selectin ligand; heparan sulfate proteoglycan; homing function and Indian blood group system; hyaluronate receptor; phagocytic glycoprotein 1; soluble CD44
CD45 CD45RA CD45RB CD45RC CD45RO,PTPRC,5788,B220 CD45 CD45R GP180 L-CA LCA LY5 T200,1q31.3-q32.1,"protein tyrosine phosphatase, receptor type C","receptor-type tyrosine-protein phosphatase C; CD45 antigen; T200 glycoprotein; T200 leukocyte common antigen; protein tyrosine phosphatase, receptor type, c polypeptide"
CD46,CD46,4179,AHUS2 MCP MIC10 TLX TRA2.10,1q32.2,CD46 molecule,"membrane cofactor protein; CD46 antigen, complement regulatory protein; CD46 molecule, complement regulatory protein; antigen identified by monoclonal antibody TRA-2-10; complement membrane cofactor protein; measles virus receptor; membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen); trophoblast leucocyte common antigen; trophoblast leukocyte common antigen; trophoblast-lymphocyte cross-reactive antigen"
CD47,CD47,961,IAP MER6 OA3,3q13.12,CD47 molecule,"leukocyte surface antigen CD47; CD47 antigen (Rh-related antigen, integrin-associated signal transducer); CD47 glycoprotein; Rh-related antigen; antigen identified by monoclonal antibody 1D8; antigenic surface determinant protein OA3; integrin associated protein; integrin-associated signal transducer"
CD48,CD48,962,BCM1 BLAST BLAST1 MEM-102 SLAMF2 hCD48 mCD48,1q23.3,CD48 molecule,CD48 antigen; B-lymphocyte activation marker BLAST-1; BCM1 surface antigen; CD48 antigen (B-cell membrane protein); SLAM family member 2; TCT.1; leukocyte antigen MEM-102; signaling lymphocytic activation molecule 2
CD49a,ITGA1,3672,CD49a VLA1,5q11.2,integrin subunit alpha 1,integrin alpha-1; CD49 antigen-like family member A; VLA-1; laminin and collagen receptor; very late activation protein 1
CD49b,ITGA2,3673,BR CD49B GPIa HPA-5 VLA-2 VLAA2,5q11.2,integrin subunit alpha 2,"integrin alpha-2; CD49 antigen-like family member B; alpha 2 subunit of VLA-2 receptor; collagen receptor; human platelet alloantigen system 5; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor); platelet antigen Br; platelet glycoprotein GPIa; platelet membrane glycoprotein Ia; very late activation protein 2 receptor, alpha-2 subunit"
CD49c,ITGA3,3675,CD49C FRP-2 GAP-B3 GAPB3 ILNEB MSK18 VCA-2 VL3A VLA3a,17q21.33,integrin subunit alpha 3,"integrin alpha-3; CD49 antigen-like family member C; alpha 3 subunit of VLA-3 receptor; antigen CD49C; antigen identified by monoclonal antibody J143; galactoprotein B3; integrin alpha 3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); testicular tissue protein Li 96; testicular tissue protein Li 98; very late activation protein 3 receptor, alpha-3 subunit"
CD49d,ITGA4,3676,CD49D IA4,2q31.3,integrin subunit alpha 4,"integrin alpha-4; 269C wild type; CD49 antigen-like family member D; VLA-4 subunit alpha; alpha 4 subunit of VLA-4 receptor; antigen CD49D, alpha-4 subunit of VLA-4 receptor; integrin alpha-IV; very late activation protein 4 receptor, alpha 4 subunit"
CD49e,ITGA5,3678,CD49e FNRA VLA-5 VLA5A,12q13.13,integrin subunit alpha 5,"integrin alpha-5; CD49 antigen-like family member E; fibronectin receptor subunit alpha; fibronectin receptor, alpha polypeptide; fibronectin receptor, alpha subunit; integrin alpha-F; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); very late activation protein 5, alpha subunit"
CD49f,ITGA6,3655,CD49f ITGA6B VLA-6,2q31.1,integrin subunit alpha 6,"integrin alpha-6; CD49 antigen-like family member F; integrin alpha6B; integrin, alpha 6"
CD50,ICAM3,3385,CD50 CDW50 ICAM-R,19p13.2,intercellular adhesion molecule 3,intercellular adhesion molecule 3; ICAM-3
CD51,ITGAV,3685,CD51 MSK8 VNRA VTNR,2q32.1,integrin subunit alpha V,"integrin alpha-V; antigen identified by monoclonal antibody L230; integrin alphaVbeta3; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); vitronectin receptor subunit alpha"
CD52,CD52,1043,CDW52,1p36.11,CD52 molecule,CAMPATH-1 antigen; CD52 antigen (CAMPATH-1 antigen); CDW52 antigen (CAMPATH-1 antigen); HEL-S-171mP; cambridge pathology 1 antigen; epididymal secretory protein E5; epididymis secretory sperm binding protein Li 171mP; he5; human epididymis-specific protein 5
CD53,CD53,963,MOX44 TSPAN25,1p13.3,CD53 molecule,leukocyte surface antigen CD53; CD53 antigen; CD53 glycoprotein; CD53 tetraspan antigen; antigen MOX44 identified by monoclonal antibody MRC-OX44; cell surface antigen; cell surface glycoprotein CD53; tetraspanin-25; transmembrane glycoprotein; tspan-25
CD54,ICAM1,3383,BB2 CD54 P3.58,19p13.2,intercellular adhesion molecule 1,"intercellular adhesion molecule 1; ICAM-1; cell surface glycoprotein P3.58; intercellular adhesion molecule 1 (CD54), human rhinovirus receptor; major group rhinovirus receptor"
CD55,CD55,1604,CR CROM DAF TC,1q32.2,CD55 molecule (Cromer blood group),"complement decay-accelerating factor; CD55 antigen; CD55 molecule, decay accelerating factor for complement (Cromer blood group)"
CD56,NCAM1,4684,CD56 MSK39 NCAM,11q23.2,neural cell adhesion molecule 1,"neural cell adhesion molecule 1; antigen recognized by monoclonal antibody 5.1H11; neural cell adhesion molecule, NCAM"
CD57,B3GAT1,27087,CD57 GLCATP GLCUATP HNK1 LEU7 NK-1 NK1,11q25,"beta-1,3-glucuronyltransferase 1","galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1; LEU7 antigen; UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase; glcUAT-P; glucuronosyltransferase P"
CD58,CD58,965,LFA-3 LFA3 ag3,1p13.1,CD58 molecule,"lymphocyte function-associated antigen 3; CD58 antigen, (lymphocyte function-associated antigen 3); surface glycoprotein LFA-3"
CD59,CD59,966,16.3A5 1F5 EJ16 EJ30 EL32 G344 HRF-20 HRF20 MAC-IP MACIF MEM43 MIC11 MIN1 MIN2 MIN3 MIRL MSK21 p18-20,11p13,CD59 molecule,"CD59 glycoprotein; 1F5 antigen; 20 kDa homologous restriction factor; CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344); CD59 molecule, complement regulatory protein; Ly-6-like protein; MEM43 antigen; T cell-activating protein; human leukocyte antigen MIC11; lymphocytic antigen CD59/MEM43; membrane attack complex (MAC) inhibition factor; membrane attack complex inhibition factor; membrane inhibitor of reactive lysis; protectin; surface anitgen recognized by monoclonal antibody 16.3A5"
CD60a,"-",-,-,-,-,-
CD60b,"-",-,-,-,-,-
CD60c,"-",-,-,-,-,-
CD61,ITGB3,3690,BDPLT16 BDPLT2 CD61 GP3A GPIIIa GT,17q21.32,integrin subunit beta 3,"integrin beta-3; antigen CD61; integrin beta 3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); platelet membrane glycoprotein IIIa"
CD62E,SELE,6401,CD62E ELAM ELAM1 ESEL LECAM2,1q24.2,selectin E,E-selectin; CD62 antigen-like family member E; ELAM-1; endothelial adhesion molecule 1; endothelial leukocyte adhesion molecule 1; leukocyte endothelial cell adhesion molecule 2
CD62L,SELL,6402,CD62L LAM1 LECAM1 LEU8 LNHR LSEL LYAM1 PLNHR TQ1,1q24.2,selectin L,L-selectin; CD62 antigen-like family member L; gp90-MEL; leukocyte surface antigen Leu-8; leukocyte-endothelial cell adhesion molecule 1; lymph node homing receptor; lymphocyte adhesion molecule 1; pln homing receptor
CD62P,SELP,6403,CD62 CD62P GMP140 GRMP LECAM3 PADGEM PSEL,1q24.2,selectin P,"P-selectin; CD62 antigen-like family member P; GMP-140; granule membrane protein 140; granule membrane protein 140kDa; granulocyte membrane protein; leukocyte-endothelial cell adhesion molecule 3; platelet activation dependent granule-external membrane protein; platelet alpha-granule membrane protein; selectin P (granule membrane protein 140kDa, antigen CD62)"
CD63,CD63,967,LAMP-3 ME491 MLA1 OMA81H TSPAN30,12q13.2,CD63 molecule,CD63 antigen; CD63 antigen (melanoma 1 antigen); granulophysin; lysosomal-associated membrane protein 3; lysosome-associated membrane glycoprotein 3; melanoma-associated antigen ME491; melanoma-associated antigen MLA1; ocular melanoma-associated antigen; tetraspanin-30; tspan-30
CD64a,FCGR1A,2209,CD64 CD64A FCRI IGFR1,1q21.2,Fc fragment of IgG receptor Ia,"high affinity immunoglobulin gamma Fc receptor I; Fc fragment of IgG, high affinity Ia, receptor (CD64); Fc fragment of IgG, high affinity Ia, receptor for (CD64); Fc gamma receptor Ia; Fc-gamma RI; Fc-gamma receptor I A1; IgG Fc receptor I; fc-gamma RIA; fcgammaRIa"
CD65,"-",-,-,-,-,-
CD65s,"-",-,-,-,-,-
CD66a,CEACAM1,634,BGP BGP1 BGPI,19q13.2,carcinoembryonic antigen related cell adhesion molecule 1,carcinoembryonic antigen-related cell adhesion molecule 1; CD66a antigen; antigen CD66; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
CD66b,CEACAM8,1088,CD66b CD67 CGM6 NCA-95,19q13.2,carcinoembryonic antigen related cell adhesion molecule 8,carcinoembryonic antigen-related cell adhesion molecule 8; CD67 antigen; carcinoembryonic antigen CGM6; carcinoembryonic antigen gene family member 6; non-specific cross-reacting antigen NCA-95
CD66c,CEACAM6,4680,CD66c CEAL NCA,19q13.2,carcinoembryonic antigen related cell adhesion molecule 6,carcinoembryonic antigen-related cell adhesion molecule 6; Cluster of Differentiation 66c; carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen); normal cross-reacting antigen
CD66d,CEACAM3,1084,CD66D CEA CGM1 W264 W282,19q13.2,carcinoembryonic antigen related cell adhesion molecule 3,carcinoembryonic antigen-related cell adhesion molecule 3; CD66d antigen; carcinoembryonic antigen CGM1; carcinoembryonic antigen gene family member 1; nonspecific cross-reacting antigen
CD66e,CEACAM5,1048,CD66e CEA,19q13.2,carcinoembryonic antigen related cell adhesion molecule 5,carcinoembryonic antigen-related cell adhesion molecule 5; meconium antigen 100
CD66f,PSG1,5669,B1G1 CD66f DHFRP2 FL-NCA-1/2 PBG1 PS-beta-C/D PS-beta-G-1 PSBG-1 PSBG1 PSG95 PSGGA PSGIIA SP1,19q13.2,pregnancy specific beta-1-glycoprotein 1,pregnancy-specific beta-1-glycoprotein 1; CD66 antigen-like family member F; fetal liver non-specific cross-reactive antigen 1/2; pregnancy-specific B-1 glycoprotein; pregnancy-specific beta-1 glycoprotein C/D
CD68,CD68,968,GP110 LAMP4 SCARD1,17p13.1,CD68 molecule,"macrosialin; CD68 antigen; macrophage antigen CD68; scavenger receptor class D, member 1"
CD69,CD69,969,AIM BL-AC/P26 CLEC2C EA1 GP32/28 MLR-3,12p13.31,CD69 molecule,"early activation antigen CD69; C-type lectin domain family 2, member C; CD69 antigen (p60, early T-cell activation antigen); activation inducer molecule (AIM/CD69); early T-cell activation antigen p60; early lymphocyte activation antigen; leukocyte surface antigen Leu-23"
CD70,CD70,970,CD27-L CD27L CD27LG TNFSF7 TNLG8A,19p13.3,CD70 molecule,CD70 antigen; CD27 ligand; Ki-24 antigen; surface antigen CD70; tumor necrosis factor ligand 8A; tumor necrosis factor ligand superfamily member 7
CD71,TFRC,7037,CD71 IMD46 T9 TFR TFR1 TR TRFR p90,3q29,transferrin receptor,transferrin receptor protein 1
CD72,CD72,971,CD72b LYB2,9p13.3,CD72 molecule,B-cell differentiation antigen CD72; CD72 antigen; lyb-2
CD73,NT5E,4907,CALJA CD73 E5NT NT NT5 NTE eN eNT,6q14.3,5'-nucleotidase ecto,5'-nucleotidase; 5'-NT; Purine 5-Prime-Nucleotidase; ecto-5'-nucleotidase
CD74,CD74,972,DHLAG HLADG II Ia-GAMMA,5q33.1,CD74 molecule,"HLA class II histocompatibility antigen gamma chain; CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); CD74 molecule, major histocompatibility complex, class II invariant chain; HLA-DR antigens-associated invariant chain; HLA-DR-gamma; Ia-associated invariant chain; MHC HLA-DR gamma chain; gamma chain of class II antigens; p33"
CD75,"-",-,-,-,-,-
CD75s,"-",-,-,-,-,-
CD77,"-",-,-,-,-,-
CD79a,CD79A,973,IGA MB-1,19q13.2,CD79a molecule,"B-cell antigen receptor complex-associated protein alpha chain; CD79a antigen (immunoglobulin-associated alpha); CD79a molecule, immunoglobulin-associated alpha; MB-1 membrane glycoprotein; ig-alpha; membrane-bound immunoglobulin-associated protein; surface IgM-associated protein"
CD79b,CD79B,974,AGM6 B29 IGB,17q23.3,CD79b molecule,"B-cell antigen receptor complex-associated protein beta chain; B-cell-specific glycoprotein B29; CD79b antigen (immunoglobulin-associated beta); CD79b molecule, immunoglobulin-associated beta; Ig-beta; immunoglobulin-associated B29 protein"
CD80,CD80,941,B7 B7-1 B7.1 BB1 CD28LG CD28LG1 LAB7,3q13.33,CD80 molecule,"T-lymphocyte activation antigen CD80; B-lymphocyte activation antigen B7; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CTLA-4 counter-receptor B7.1; activation B7-1 antigen; costimulatory factor CD80; costimulatory molecule variant IgV-CD80"
CD81,CD81,975,CVID6 S5.7 TAPA1 TSPAN28,11p15.5,CD81 molecule,CD81 antigen; 26 kDa cell surface protein TAPA-1; CD81 antigen (target of antiproliferative antibody 1); tetraspanin-28; tspan-28
CD82,CD82,3732,4F9 C33 GR15 IA4 KAI1 R2 SAR2 ST6 TSPAN27,11p11.2,CD82 molecule,"CD82 antigen; C33 antigen; inducible membrane protein R2; kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)); metastasis suppressor Kangai-1; tetraspanin-27; tspan-27"
CD83,CD83,9308,BL11 HB15,6p23,CD83 molecule,"CD83 antigen; B-cell activation protein; CD83 antigen (activated B lymphocytes, immunoglobulin superfamily); cell surface protein HB15; cell-surface glycoprotein; hCD83"
CD84,CD84,8832,LY9B SLAMF5 hCD84 mCD84,1q23.3,CD84 molecule,SLAM family member 5; CD84 antigen (leukocyte antigen); cell surface antigen MAX.3; hly9-beta; leucocyte differentiation antigen CD84; leukocyte antigen CD84; leukocyte differentiation antigen CD84; signaling lymphocytic activation molecule 5
CD85A,LILRB3,11025,CD85A HL9 ILT-5 ILT5 LILRA6 LIR-3 LIR3 PIR-B PIRB,19q13.42,leukocyte immunoglobulin like receptor B3,"leukocyte immunoglobulin-like receptor subfamily B member 3; CD85 antigen-like family member A; immunoglobulin-like transcript 5; leucocyte Ig-like receptor B3; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3; monocyte inhibitory receptor HL9"
CD85B,LILRA6,79168,CD85b ILT-8 ILT5 ILT8 LILRB3 LILRB6,19q13.42,leukocyte immunoglobulin like receptor A6,"leukocyte immunoglobulin-like receptor subfamily A member 6; LOW QUALITY PROTEIN: leukocyte immunoglobulin-like receptor subfamily A member 6; immunoglobulin-like transcript 5; immunoglobulin-like transcript 8; leucocyte Ig-like receptor A6; leukocyte Ig-like receptor; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 6"
CD85C,LILRB5,10990,CD85C LIR-8 LIR8,19q13.42,leukocyte immunoglobulin like receptor B5,"leukocyte immunoglobulin-like receptor subfamily B member 5; CD85 antigen-like family member C; leucocyte Ig-like receptor B5; leukocyte immunoglobulin-like receptor 8; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5"
CD85D,LILRB2,10288,CD85D ILT-4 ILT4 LIR-2 LIR2 MIR-10 MIR10,19q13.42,leukocyte immunoglobulin like receptor B2,"leukocyte immunoglobulin-like receptor subfamily B member 2; CD85 antigen-like family member D; Ig-like transcript 4; leucocyte Ig-like receptor B2; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2; monocyte/macrophage immunoglobulin-like receptor 10; myeloid inhibitory receptor 10"
CD85F,LILRA5,353514,CD85 CD85F ILT-11 ILT11 LILRB7 LIR-9 LIR9,19q13.42,leukocyte immunoglobulin like receptor A5,"leukocyte immunoglobulin-like receptor subfamily A member 5; CD85 antigen-like family member F; immunoglobulin-like transcript 11 protein; leucocyte Ig-like receptor A5; leukocyte Ig-like receptor 9; leukocyte immunoglobulin-like receptor 9; leukocyte immunoglobulin-like receptor subfamily A member 5 soluble; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 7"
CD85G,LILRA4,23547,CD85g ILT7,19q13.42,leukocyte immunoglobulin like receptor A4,"leukocyte immunoglobulin-like receptor subfamily A member 4; CD85 antigen-like family member G; immunoglobulin-like transcript 7; leucocyte Ig-like receptor A4; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4"
CD85H,LILRA2,11027,CD85H ILT1 LIR-7 LIR7,19q13.42,leukocyte immunoglobulin like receptor A2,"leukocyte immunoglobulin-like receptor subfamily A member 2; CD85 antigen-like family member H; immunoglobulin-like transcript 1; leucocyte Ig-like receptor A2; leukocyte immunoglobulin-like receptor 7; leukocyte immunoglobulin-like receptor subfamily A member 2 soluble; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2"
CD85I,LILRA1,11024,CD85I LIR-6 LIR6,19q13.42,leukocyte immunoglobulin like receptor A1,"leukocyte immunoglobulin-like receptor subfamily A member 1; CD85 antigen-like family member I; leucocyte Ig-like receptor A1; leukocyte immunoglobulin-like receptor 6; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1"
CD85J,LILRB1,10859,CD85J ILT-2 ILT2 LIR-1 LIR1 MIR-7 MIR7 PIR-B PIRB,19q13.42,leukocyte immunoglobulin like receptor B1,"leukocyte immunoglobulin-like receptor subfamily B member 1; CD85 antigen-like family member J; Ig-like transcript 2; leucocyte Ig-like receptor B1; leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1; monocyte/macrophage immunoglobulin-like receptor 7; myeloid inhibitory receptor 7"
CD85K,LILRB4,11006,CD85K ILT-3 ILT3 LIR-5 LIR5,19q13.42,leukocyte immunoglobulin like receptor B4,"leukocyte immunoglobulin-like receptor subfamily B member 4; CD85 antigen-like family member K; immunoglobulin-like transcript 3; leucocyte Ig-like receptor B4; leukocyte immunoglobulin-like receptor 5; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4; monocyte inhibitory receptor HM18"
CD85M,LILRP2,79166,CD85m ILT10 LILRA5,19q13.42,leukocyte immunoglobulin-like receptor pseudogene 2,"immunoglobulin-like transcript 10; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 5"
CD86,CD86,942,B7-2 B7.2 B70 CD28LG2 LAB72,3q13.33,CD86 molecule,"T-lymphocyte activation antigen CD86; B-lymphocyte activation antigen B7-2; BU63; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen); CTLA-4 counter-receptor B7.2; FUN-1"
CD87,PLAUR,5329,CD87 U-PAR UPAR URKR,19q13.31,"plasminogen activator, urokinase receptor",urokinase plasminogen activator surface receptor; monocyte activation antigen Mo3; u-plasminogen activator receptor form 2; urokinase-type plasminogen activator (uPA) receptor
CD88,C5AR1,728,C5A C5AR C5R1 CD88,19q13.32,complement C5a receptor 1,C5a anaphylatoxin chemotactic receptor 1; C5a anaphylatoxin receptor; C5a ligand; C5a-R; complement component 5 receptor 1; complement component 5a receptor 1
CD89,FCAR,2204,CD89 CTB-61M7.2 FcalphaRI,19q13.42,Fc fragment of IgA receptor,"immunoglobulin alpha Fc receptor; FCAR variant 14; Fc alpha receptor; Fc fragment of IgA, receptor for"
CD90,THY1,7070,CD90 CDw90,11q23.3,Thy-1 cell surface antigen,thy-1 membrane glycoprotein; Thy-1 T-cell antigen; thy-1 antigen
CD91,LRP1,4035,A2MR APOER APR CD91 IGFBP3R KPA LRP LRP1A TGFBR5,12q13.3,LDL receptor related protein 1,prolow-density lipoprotein receptor-related protein 1; TbetaR-V/LRP-1/IGFBP-3 receptor; alpha-2-macroglobulin receptor; apolipoprotein E receptor; low density lipoprotein receptor-related protein 1; type V tgf-beta receptor
CD92,SLC44A1,23446,CD92 CDW92 CHTL1 CTL1,9q31.1-q31.2,solute carrier family 44 member 1,"choline transporter-like protein 1; CDW92 antigen; solute carrier family 44 (choline transporter), member 1"
CD93,CD93,22918,C1QR1 C1qR(P) C1qRP CDw93 ECSM3 MXRA4 dJ737E23.1,20p11.21,CD93 molecule,complement component C1q receptor; C1q receptor 1; C1q/MBL/SPA receptor; C1qR; CD93 antigen; complement component 1 q subcomponent receptor 1; matrix-remodeling-associated protein 4; matrix-remodelling associated 4
CD94,KLRD1,3824,CD94,12p13.2,killer cell lectin like receptor D1,"natural killer cells antigen CD94; CD94 antigen; KP43; NK cell receptor; killer cell lectin-like receptor subfamily D, member 1"
CD95,FAS,355,ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6,10q23.31,Fas cell surface death receptor,"tumor necrosis factor receptor superfamily member 6; APO-1 cell surface antigen; CD95 antigen; FASLG receptor; Fas (TNF receptor superfamily, member 6); Fas AMA; TNF receptor superfamily member 6; apoptosis antigen 1; apoptosis signaling receptor FAS; apoptosis-mediating surface antigen FAS; mutant tumor necrosis receptor superfamily member 6; tumor necrosis factor receptor superfamily, member 6"
CD96,CD96,10225,TACTILE,3q13.13-q13.2,CD96 molecule,"T-cell surface protein tactile; T cell activation, increased late expression; cell surface antigen CD96; t cell-activated increased late expression protein"
CD97,ADGRE5,976,CD97 TM7LN1,19p13.12,adhesion G protein-coupled receptor E5,"CD97 antigen; CD97 molecule; leukocyte antigen CD97; seven transmembrane helix receptor; seven-span transmembrane protein; seven-transmembrane, heterodimeric receptor associated with inflammation"
CD98,SLC3A2,6520,4F2 4F2HC 4T2HC CD98 CD98HC MDU1 NACAE,11q12.3,solute carrier family 3 member 2,"4F2 cell-surface antigen heavy chain; CD98 heavy chain; antigen defined by monoclonal antibody 4F2, heavy chain; antigen identified by monoclonal antibodies 4F2, TRA1.10, TROP4, and T43; lymphocyte activation antigen 4F2 large subunit; monoclonal antibody 44D7; solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2; solute carrier family 3 (amino acid transporter heavy chain), member 2"
CD99,CD99,4267,HBA71 MIC2 MIC2X MIC2Y MSK5X,Xp22.33 and Yp11.2,CD99 molecule,"CD99 antigen; E2 antigen; MIC2 (monoclonal antibody 12E7); T-cell surface glycoprotein E2; antigen identified by monoclonal 12E7, Y homolog; antigen identified by monoclonal antibodies 12E7, F21 and O13; cell surface antigen 12E7; cell surface antigen HBA-71; cell surface antigen O13; surface antigen MIC2"
CD100,SEMA4D,10507,C9orf164 CD100 M-sema-G SEMAJ coll-4,9q22.2,semaphorin 4D,"semaphorin-4D; A8; BB18; GR3; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D"
CD101,CD101,9398,EWI-101 IGSF2 V7,1p13.1,CD101 molecule,immunoglobulin superfamily member 2; cell surface glycoprotein V7; glu-Trp-Ile EWI motif-containing protein 101; leukocyte surface protein
CD102,ICAM2,3384,CD102,17q23.3,intercellular adhesion molecule 2,intercellular adhesion molecule 2; ICAM-2
CD103,ITGAE,3682,CD103 HUMINAE,17p13.2,integrin subunit alpha E,"integrin alpha-E; HML-1 antigen; antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide; human mucosal lymphocyte antigen 1, alpha polypeptide; integrin alpha-IEL; integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide); mucosal lymphocyte 1 antigen"
CD104,ITGB4,3691,CD104 GP150,17q25.1,integrin subunit beta 4,integrin beta-4; CD104 antigen
CD105,ENG,2022,END HHT1 ORW1,9q34.11,endoglin,endoglin; CD105 antigen
CD106,VCAM1,7412,CD106 INCAM-100,1p21.2,vascular cell adhesion molecule 1,vascular cell adhesion protein 1; CD106 antigen
CD107a,LAMP1,3916,CD107a LAMPA LGP120,13q34,lysosomal associated membrane protein 1,lysosome-associated membrane glycoprotein 1; CD107 antigen-like family member A; LAMP-1; lysosome-associated membrane protein 1
CD107b,LAMP2,3920,CD107b LAMP-2 LAMPB LGP-96 LGP110,Xq24,lysosomal associated membrane protein 2,lysosome-associated membrane glycoprotein 2; CD107 antigen-like family member B
CD108,SEMA7A,8482,CD108 CDw108 H-SEMA-K1 H-Sema-L JMH SEMAK1 SEMAL,15q24.1,semaphorin 7A (John Milton Hagen blood group),"semaphorin-7A; JMH blood group antigen; John Milton Hagen blood group H-Sema K1; john-Milton-Hargen human blood group Ag; sema K1; sema L; sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A (JMH blood group); sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, 7A; semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group); semaphorin-K1; semaphorin-L"
CD109,CD109,135228,CPAMD7 p180 r150,6q13,CD109 molecule,CD109 antigen; 150 kDa TGF-beta-1-binding protein; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7; Gov platelet alloantigens; activated T-cell marker CD109; platelet-specific Gov antigen
CD110,MPL,4352,C-MPL CD110 MPLV THCYT2 TPOR,1p34.2,"MPL proto-oncogene, thrombopoietin receptor",thrombopoietin receptor; TPO-R; myeloproliferative leukemia protein; myeloproliferative leukemia virus oncogene; proto-oncogene c-Mpl
CD111,NECTIN1,5818,CD111 CLPED1 ED4 HIgR HV1S HVEC OFC7 PRR PRR1 PVRL1 PVRR PVRR1 SK-12 nectin-1,11q23.3,nectin cell adhesion molecule 1,nectin-1; ectodermal dysplasia 4 (Margarita Island type); herpes simplex virus type 1 sensitivity; herpes virus entry mediator C; herpesvirus Ig-like receptor; nectin 1; poliovirus receptor-like 1; poliovirus receptor-related 1 (herpesvirus entry mediator C); poliovirus receptor-related protein 1
CD112,NECTIN2,5819,CD112 HVEB PRR2 PVRL2 PVRR2,19q13.32,nectin cell adhesion molecule 2,nectin-2; herpesvirus entry protein B; poliovirus receptor-like 2; poliovirus receptor-related 2 (herpesvirus entry mediator B)
CD113,NECTIN3,25945,CD113 CDW113 NECTIN-3 PPR3 PRR3 PVRL3 PVRR3,3q13.13,nectin cell adhesion molecule 3,nectin-3; nectin 3; poliovirus receptor-related 3; poliovirus receptor-related protein 3
CD114,CSF3R,1441,CD114 GCSFR SCN7,1p34.3,colony stimulating factor 3 receptor,granulocyte colony-stimulating factor receptor; CD114 antigen; G-CSF receptor; G-CSF-R; colony stimulating factor 3 receptor (granulocyte)
CD115,CSF1R,1436,C-FMS CD115 CSF-1R CSFR FIM2 FMS HDLS M-CSF-R,5q32,colony stimulating factor 1 receptor,macrophage colony-stimulating factor 1 receptor; CD115 antigen; CSF-1 receptor; FMS proto-oncogene; McDonough feline sarcoma viral (v-fms) oncogene homolog; macrophage colony stimulating factor I receptor; proto-oncogene c-Fms
CD116,CSF2RA,1438,CD116 CDw116 CSF2R CSF2RAX CSF2RAY CSF2RX CSF2RY GM-CSF-R-alpha GMCSFR GMR SMDP4,Xp22.33 and Yp11.2,colony stimulating factor 2 receptor alpha subunit,"granulocyte-macrophage colony-stimulating factor receptor subunit alpha; CD116 antigen; GM-CSF receptor alpha subunit; GMCSFR-alpha; GMR-alpha; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage); granulocyte-macrophage colony-stimulating factor receptor alpha chain"
CD117,KIT,3815,C-Kit CD117 PBT SCFR,4q12,KIT proto-oncogene receptor tyrosine kinase,mast/stem cell growth factor receptor Kit; c-Kit protooncogene; p145 c-kit; piebald trait protein; proto-oncogene c-Kit; proto-oncogene tyrosine-protein kinase Kit; soluble KIT variant 1; tyrosine-protein kinase Kit; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein
CD118,LIFR,3977,CD118 LIF-R SJS2 STWS SWS,5p13.1,leukemia inhibitory factor receptor alpha,leukemia inhibitory factor receptor; CD118 antigen; LIF receptor
CD119,IFNGR1,3459,CD119 IFNGR IMD27A IMD27B,6q23.3,interferon gamma receptor 1,"interferon gamma receptor 1; AVP, type 2; CD119 antigen; CDw119; IFN-gamma receptor 1; IFN-gamma-R-alpha; IFN-gamma-R1; antiviral protein, type 2; immune interferon receptor 1; interferon-gamma receptor alpha chain"
CD120a,TNFRSF1A,7132,CD120a FPF TBP1 TNF-R TNF-R-I TNF-R55 TNFAR TNFR1 TNFR55 TNFR60 p55 p55-R p60,12p13.31,TNF receptor superfamily member 1A,tumor necrosis factor receptor superfamily member 1A; TNF-R1; TNF-RI; TNFR-I; tumor necrosis factor binding protein 1; tumor necrosis factor receptor 1A isoform beta; tumor necrosis factor receptor type 1; tumor necrosis factor-alpha receptor
CD120b,TNFRSF1B,7133,CD120b TBPII TNF-R-II TNF-R75 TNFBR TNFR1B TNFR2 TNFR80 p75 p75TNFR,1p36.22,TNF receptor superfamily member 1B,tumor necrosis factor receptor superfamily member 1B; TNF-R2; TNF-RII; p75 TNF receptor; p80 TNF-alpha receptor; soluble TNFR1B variant 1; tumor necrosis factor beta receptor; tumor necrosis factor binding protein 2; tumor necrosis factor receptor 2; tumor necrosis factor receptor type II
CD121a,IL1R1,3554,CD121A D2S1473 IL-1R-alpha IL1R IL1RA P80,2q11.2-q12.1,interleukin 1 receptor type 1,"interleukin-1 receptor type 1; CD121 antigen-like family member A; IL-1R-1; IL-1RT-1; IL-1RT1; interleukin 1 receptor alpha, type I; interleukin-1 receptor alpha; interleukin-1 receptor type I"
CD121b,IL1R2,7850,CD121b CDw121b IL-1R-2 IL-1RT-2 IL-1RT2 IL1R2c IL1RB,2q11.2,interleukin 1 receptor type 2,"interleukin-1 receptor type 2; CD121 antigen-like family member B; IL-1 type II receptor; IL-1R-beta; antigen CDw121b; interleukin 1 receptor type II variant 3; interleukin-1 receptor beta; interleukin-1 receptor type II; type II interleukin-1 receptor, beta"
CD122,IL2RB,3560,CD122 IL15RB P70-75,22q12.3,interleukin 2 receptor subunit beta,"interleukin-2 receptor subunit beta; CD122 antigen; IL-2 receptor subunit beta; IL-2R subunit beta; IL-2RB; high affinity IL-2 receptor beta subunit; high affinity IL-2 receptor subunit beta; interleukin 15 receptor, beta; interleukin 2 receptor, beta; p75"
CD123,IL3RA,3563,CD123 IL3R IL3RAY IL3RX IL3RY hIL-3Ra,Xp22.33 and Yp11.2,interleukin 3 receptor subunit alpha,"interleukin-3 receptor subunit alpha; CD123 antigen; IL-3 receptor alpha SP2 isoform; IL-3 receptor subunit alpha; IL-3R subunit alpha; IL-3R-alpha; IL-3RA; interleukin 3 receptor, alpha (low affinity)"
CD124,IL4R,3566,CD124 IL-4RA IL4RA,16p12.1,interleukin 4 receptor,interleukin-4 receptor subunit alpha; IL-4 receptor subunit alpha; IL4R nirs variant 1; interleukin 13 receptor; interleukin-4 receptor alpha chain
CD125,IL5RA,3568,CD125 CDw125 HSIL5R3 IL5R,3p26.2,interleukin 5 receptor subunit alpha,"interleukin-5 receptor subunit alpha; CD125 antigen; IL-5 receptor subunit alpha; IL-5R subunit alpha; interleukin 5 receptor type 3; interleukin 5 receptor, alpha; interleukin-5 receptor alpha chain"
CD126,IL6R,3570,CD126 IL-6R-1 IL-6RA IL6Q IL6RA IL6RQ gp80,1q21.3,interleukin 6 receptor,interleukin-6 receptor subunit alpha; CD126 antigen; IL-6 receptor subunit alpha; IL-6R 1; membrane glycoprotein 80
CD127,IL7R,3575,CD127 CDW127 IL-7R-alpha IL7RA ILRA,5p13.2,interleukin 7 receptor,interleukin-7 receptor subunit alpha; CD127 antigen; IL-7 receptor subunit alpha; IL-7R subunit alpha; interleukin 7 receptor alpha chain; interleukin 7 receptor isoform H5-6
CD129,IL9R,3581,CD129 IL-9R,Xq28 and Yq12,interleukin 9 receptor,interleukin-9 receptor; IL-9 receptor
CD130,IL6ST,3572,CD130 CDW130 GP130 IL-6RB,5q11.2,interleukin 6 signal transducer,"interleukin-6 receptor subunit beta; CD130 antigen; IL-6 receptor subunit beta; IL-6R subunit beta; gp130 of the rheumatoid arthritis antigenic peptide-bearing soluble form; gp130, oncostatin M receptor; interleukin receptor beta chain; membrane glycoprotein 130; membrane glycoprotein gp130; oncostatin-M receptor subunit alpha"
CD131,CSF2RB,1439,CD131 CDw131 IL3RB IL5RB SMDP5,22q12.3,colony stimulating factor 2 receptor beta common subunit,"cytokine receptor common subunit beta; GM-CSF/IL-3/IL-5 receptor common beta subunit; GM-CSF/IL-3/IL-5 receptor common beta-chain; beta common cytokine receptor; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); colony-stimulating factor-2 receptor, beta, low-affinity; interleukin 3 receptor/granulocyte-macrophage colony stimulating factor 3 receptor, beta (high affinity)"
CD132,IL2RG,3561,CD132 CIDX IL-2RG IMD4 P64 SCIDX SCIDX1,Xq13.1,interleukin 2 receptor subunit gamma,"cytokine receptor common subunit gamma; CD132 antigen; IL-2 receptor subunit gamma; IL-2R subunit gamma; common cytokine receptor gamma chain; gammaC; interleukin 2 receptor, gamma"
CD133,PROM1,8842,AC133 CD133 CORD12 MCDR2 MSTP061 PROML1 RP41 STGD4,4p15.32,prominin 1,prominin-1; antigen AC133; hProminin; hematopoietic stem cell antigen; prominin-like protein 1
CD134,TNFRSF4,7293,ACT35 CD134 IMD16 OX40 TXGP1L,1p36.33,TNF receptor superfamily member 4,tumor necrosis factor receptor superfamily member 4; ACT35 antigen; ATC35 antigen; CD134 antigen; OX40 antigen; OX40 cell surface antigen; OX40 homologue; OX40L receptor; TAX transcriptionally-activated glycoprotein 1 receptor; lymphoid activation antigene ACT35; tax-transcriptionally activated glycoprotein 1 receptor
CD135,FLT3,2322,CD135 FLK-2 FLK2 STK1,13q12.2,fms related tyrosine kinase 3,receptor-type tyrosine-protein kinase FLT3; CD135 antigen; FL cytokine receptor; fetal liver kinase 2; fms-like tyrosine kinase 3; growth factor receptor tyrosine kinase type III; stem cell tyrosine kinase 1
CD136,MST1R,4486,CD136 CDw136 NPCA3 PTK8 RON,3p21.31,macrophage stimulating 1 receptor,macrophage-stimulating protein receptor; MSP receptor; PTK8 protein tyrosine kinase 8; c-met-related tyrosine kinase; p185-Ron
CD137,TNFRSF9,3604,4-1BB CD137 CDw137 ILA,1p36.23,TNF receptor superfamily member 9,"tumor necrosis factor receptor superfamily member 9; 4-1BB ligand receptor; CD137 antigen; T cell antigen ILA; T-cell antigen 4-1BB homolog; homolog of mouse 4-1BB; induced by lymphocyte activation (ILA); interleukin-activated receptor, homolog of mouse Ly63; receptor protein 4-1BB"
CD138,SDC1,6382,CD138 SDC SYND1 syndecan,2p24.1,syndecan 1,syndecan-1; CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; syndecan proteoglycan 1
CD140a,PDGFRA,5156,CD140A PDGFR-2 PDGFR2,4q12,platelet derived growth factor receptor alpha,"platelet-derived growth factor receptor alpha; CD140 antigen-like family member A; CD140a antigen; PDGF-R-alpha; alpha-type platelet-derived growth factor receptor; platelet-derived growth factor receptor 2; platelet-derived growth factor receptor, alpha polypeptide"
CD140b,PDGFRB,5159,CD140B IBGC4 IMF1 JTK12 KOGS PDGFR PDGFR-1 PDGFR1 PENTT,5q32,platelet derived growth factor receptor beta,"platelet-derived growth factor receptor beta; Activated tyrosine kinase PDGFRB; CD140 antigen-like family member B; NDEL1-PDGFRB; PDGF-R-beta; PDGFR-beta; beta-type platelet-derived growth factor receptor; platelet-derived growth factor receptor 1; platelet-derived growth factor receptor, beta polypeptide"
CD141,THBD,7056,AHUS6 BDCA3 CD141 THPH12 THRM TM,20p11.21,thrombomodulin,thrombomodulin; CD141 antigen; fetomodulin
CD142,F3,2152,CD142 TF TFA,1p21.3,"coagulation factor III, tissue factor","tissue factor; coagulation factor III (thromboplastin, tissue factor)"
CD143,ACE,1636,ACE1 CD143 DCP DCP1,17q23.3,angiotensin I converting enzyme,"angiotensin-converting enzyme; CD143 antigen; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1; angiotensin converting enzyme, somatic isoform; carboxycathepsin; dipeptidyl carboxypeptidase 1; dipeptidyl carboxypeptidase I; kininase II; peptidase P"
CD144,CDH5,1003,7B4 CD144,16q21,cadherin 5,"cadherin-5; 7B4 antigen; VE-cadherin; cadherin 5, type 2 (vascular endothelium); cadherin 5, type 2, VE-cadherin (vascular epithelium); cd144 antigen; endothelial-specific cadherin; vascular endothelial cadherin"
CD146,MCAM,4162,CD146 MUC18,11q23.3,melanoma cell adhesion molecule,cell surface glycoprotein MUC18; Gicerin; S-endo 1 endothelial-associated antigen; cell surface glycoprotein P1H12; melanoma adhesion molecule; melanoma-associated antigen A32; melanoma-associated antigen MUC18
CD147,BSG,682,5F7 CD147 EMMPRIN OK TCSF,19p13.3,basigin (Ok blood group),basigin; OK blood group antigen; collagenase stimulatory factor; extracellular matrix metalloproteinase inducer; leukocyte activation antigen M6; tumor cell-derived collagenase stimulatory factor
CD148,PTPRJ,5795,CD148 DEP1 HPTPeta R-PTP-ETA SCC1,11p11.2,"protein tyrosine phosphatase, receptor type J","receptor-type tyrosine-protein phosphatase eta; CD148 antigen; DEP-1; HPTP eta; R-PTP-J; density-enhanced phosphatase 1; human density enhanced phosphatase-1; protein tyrosine phosphatase, receptor type, J polypeptide; protein-tyrosine phosphatase eta; susceptibility to colon cancer 1, mouse, homolog of"
CD150,SLAMF1,6504,CD150 CDw150 SLAM,1q23.3,signaling lymphocytic activation molecule family member 1,signaling lymphocytic activation molecule; IPO-3; SLAM family member 1
CD151,CD151,977,GP27 MER2 PETA-3 RAPH SFA1 TSPAN24,11p15.5,CD151 molecule (Raph blood group),CD151 antigen; CD151 antigen (Raph blood group); hemidesmosomal tetraspanin CD151; membrane glycoprotein SFA-1; platelet surface glycoprotein gp27; platelet-endothelial cell tetraspan antigen 3; platelet-endothelial tetraspan antigen 3; tetraspanin-24; tspan-24
CD152,CTLA4,1493,ALPS5 CD CD152 CELIAC3 CTLA-4 GRD4 GSE IDDM12,2q33.2,cytotoxic T-lymphocyte associated protein 4,cytotoxic T-lymphocyte protein 4; CD152 isoform; celiac disease 3; cytotoxic T lymphocyte associated antigen 4 short spliced form; cytotoxic T-lymphocyte-associated serine esterase-4; insulin-dependent diabetes mellitus 12; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
CD153,TNFSF8,944,CD153 CD30L CD30LG TNLG3A,9q32-q33.1,TNF superfamily member 8,"tumor necrosis factor ligand superfamily member 8; CD153 antigen; CD30 antigen ligand; CD30 ligand; CD30-L; tumor necrosis factor (ligand) superfamily, member 8; tumor necrosis factor ligand 3A; tumor necrosis factor superfamily member 8"
CD154,CD40LG,959,CD154 CD40L HIGM1 IGM IMD3 T-BAM TNFSF5 TRAP gp39 hCD40L,Xq26.3,CD40 ligand,CD40 ligand; CD40 antigen ligand; CD40-L; T-B cell-activating molecule; T-cell antigen Gp39; TNF-related activation protein; tumor necrosis factor (ligand) superfamily member 5
CD155,PVR,5817,CD155 HVED NECL5 Necl-5 PVS TAGE4,19q13.31,poliovirus receptor,poliovirus receptor; nectin-like protein 5
CD156a,ADAM8,101,CD156 CD156a MS2,10q26.3,ADAM metallopeptidase domain 8,disintegrin and metalloproteinase domain-containing protein 8; a disintegrin and metalloproteinase domain 8; cell surface antigen MS2; human leukocyte differentiation antigen
CD156b,ADAM17,6868,ADAM18 CD156B CSVP NISBD NISBD1 TACE,2p25.1,ADAM metallopeptidase domain 17,"disintegrin and metalloproteinase domain-containing protein 17; ADAM metallopeptidase domain 18; TNF-alpha convertase; TNF-alpha converting enzyme; snake venom-like protease; tumor necrosis factor, alpha, converting enzyme"
CD156C,ADAM10,102,AD10 AD18 CD156c CDw156 HsT18717 MADM RAK kuz,15q21.3,ADAM metallopeptidase domain 10,disintegrin and metalloproteinase domain-containing protein 10; a disintegrin and metalloprotease domain 10; kuzbanian protein homolog; mammalian disintegrin-metalloprotease
CD157,BST1,683,CD157,4p15.32,bone marrow stromal cell antigen 1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2; ADP-ribosyl cyclase 2; NAD(+) nucleosidase; bone marrow stromal antigen 1; cADPr hydrolase 2; cyclic ADP-ribose hydrolase 2
CD158A,KIR2DL1,3802,CD158A KIR-K64 KIR221 NKAT NKAT-1 NKAT1 p58.1,19q13.42,"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","killer cell immunoglobulin-like receptor 2DL1; CD158 antigen-like family member A; MHC class I NK cell receptor; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer inhibitory receptor 2-2-1; natural killer-associated transcript 1; p58 NK cell inhibitory receptor NKR-K6; p58 NK receptor CL-42/47.11; p58 killer cell inhibitory receptor KIR-K64; p58 natural killer cell receptor clones CL-42/47.11; p58.1 MHC class-I-specific NK receptor"
CD158B1,KIR2DL2,3803,CD158B1 CD158b NKAT-6 NKAT6 p58.2,19q13.4,"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2","killer cell immunoglobulin-like receptor 2DL2; CD158 antigen-like family member B1; MHC class I NK cell receptor; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; natural killer-associated transcript 6; p58 NK receptor CL-43; p58 natural killer cell receptor clone CL-43"
CD158B2,KIR2DL3,3804,CD158B2 CD158b GL183 KIR-023GB KIR-K7b KIR-K7c KIR2DS5 KIRCL23 NKAT NKAT2 NKAT2A NKAT2B p58,19q13.42,"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3","killer cell immunoglobulin-like receptor 2DL3; CD158 antigen-like family member B2; NKAT-2; killer cell immunoglobulin-like receptor two domains long cytoplasmic tail 3; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; killer inhibitory receptor cl 2-3; natural killer associated transcript 2; natural killer cell inhibitory receptor KIR2DL3; p58 NK receptor CL-6; p58 natural killer cell receptor clone CL-6; p58.2 MHC class-I specific NK receptor"
CD158C,KIR3DP1,548594,CD158c KIR2DS6 KIR3DS2P KIR48 KIRX,19q13.42,"killer cell immunoglobulin like receptor, three Ig domains pseudogene 1","killer cell immunoglobulin-like receptor, three domains, pseudogene 1; killer-cell Ig-like receptor pseudogene"
CD158D,KIR2DL4,3805,CD158D G9P KIR-103AS KIR-2DL4 KIR103 KIR103AS,19q13.42,"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","killer cell immunoglobulin-like receptor 2DL4; CD158 antigen-like family member D; MHC class I NK cell receptor KIR103AS; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4; killer cell inhibitory receptor 103AS"
CD158E1,KIR3DL1,3811,CD158E1 KIR KIR3DL1/S1 NKAT-3 NKAT3 NKB1 NKB1B,19q13.42,"killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1","killer cell immunoglobulin-like receptor 3DL1; CD158 antigen-like family member E; HLA-BW4-specific inhibitory NK cell receptor; KIR antigen 3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; natural killer-associated transcript 3; p70 NK receptor CL-2/CL-11; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clones CL-2/CL-11"
CD158E2,KIR3DS1,3813,CD158E2 KIR-123FM KIR-G1 NKAT-10 NKAT10,19q13.4,"killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1","killer cell immunoglobulin-like receptor 3DS1; killer cell immunoglobulin-like receptor KIR3DS1; killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1; natural killer-associated transcript 10"
CD158F,KIR2DL5A,57292,CD158F KIR2DL5 KIR2DL5.1 KIR2DL5.3,19p13.3,"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A","killer cell immunoglobulin-like receptor 2DL5A; killer cell immunoglobulin-like receptor KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A"
CD158G,KIR2DS5,3810,CD158G NKAT9,19q13.4,"killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5","killer cell immunoglobulin-like receptor 2DS5; LOW QUALITY PROTEIN: killer cell immunoglobulin-like receptor 2DS5; CD158 antigen-like family member G; NKAT-9; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; natural killer cell inhibitory receptor; natural killer-associated transcript 9"
CD158H,KIR2DS1,3806,CD158H CD158a p50.1,19q13.4,"killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1","killer cell immunoglobulin-like receptor 2DS1; CD158 antigen-like family member H; MHC class I NK cell receptor Eb6 ActI; killer cell immunoglobulin-like receptor KIRDS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; killer-cell immunoglobulin-like receptor"
CD158I,KIR2DS4,3809,CD158I KIR-2DS4 KIR1D KIR412 KKA3 NKAT-8 NKAT8,19q13.42,"killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","killer cell immunoglobulin-like receptor 2DS4; CD158 antigen-like family member I; KIR antigen 2DS4; P58 natural killer cell receptor clones CL-39/CL-17; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; killer inhibitory receptor 4-1-2; natural killer-associated transcript 8; p50 killer cell activating receptor KAR-K1d; p58 NK receptor CL-39/CL-17"
CD158J,KIR2DS2,100132285,183ActI CD158J CD158b KIR-2DS2 NKAT-5 NKAT5 cl-49,19q13.4,"killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2","killer cell immunoglobulin-like receptor 2DS2; CD158 antigen-like family member J; MHC class I NK cell receptor; NK receptor 183 ActI; killer cell immunoglobulin-like receptor KIR2DS2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; killer-cell Ig-like receptor; killer-cell immunoglobulin-like receptor two domains short tail 2 protein; natural killer associated transcript 5; natural killer cell inhibitory receptor; p58 killer cell inhibitory receptor KIR-K7a; p58 natural killer cell receptor clone CL-49"
CD158K,KIR3DL2,3812,3DL2 CD158K KIR-3DL2 NKAT-4 NKAT4 NKAT4B p140,19q13.42,"killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","killer cell immunoglobulin-like receptor 3DL2; CD158 antigen-like family member K; KIR antigen 3DL2; MHC class I NK cell receptor; killer Ig receptor; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; killer-cell immunoglobulin-like receptor; natural killer-associated transcript 4; p70 NK receptor CL-5; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clone CL-5"
CD159a,KLRC1,3821,CD159A NKG2 NKG2A,12p13.2,killer cell lectin like receptor C1,"NKG2-A/NKG2-B type II integral membrane protein; C-lectin type II protein; CD159 antigen-like family member A; NK cell receptor A; NKG2-1/B activating NK receptor; NKG2-A/B type II integral membrane protein; NKG2-A/B-activating NK receptor; killer cell lectin-like receptor subfamily C, member 1; natural killer cell lectin; natural killer group protein 2"
CD159c,KLRC2,3822,CD159c NKG2-C NKG2C,12p13.2,killer cell lectin like receptor C2,"NKG2-C type II integral membrane protein; CD159 antigen-like family member C; NK cell receptor C; NKG2-C-activating NK receptor; killer cell lectin-like receptor subfamily C, member 2"
CD160,CD160,11126,BY55 NK1 NK28,1q21.1,CD160 molecule,"CD160 antigen; CD160 transmembrane isoform; CD160-delta Ig; natural killer cell receptor BY55; natural killer cell receptor, immunoglobulin superfamily member"
CD161,KLRB1,3820,CD161 CLEC5B NKR NKR-P1 NKR-P1A NKRP1A hNKR-P1A,12p13.31,killer cell lectin like receptor B1,"killer cell lectin-like receptor subfamily B member 1; C-type lectin domain family 5 member B; killer cell lectin-like receptor subfamily B, member 1; natural killer cell surface protein P1A"
CD162,SELPLG,6404,CD162 CLA PSGL-1 PSGL1,12q24.11,selectin P ligand,P-selectin glycoprotein ligand 1; cutaneous lymphocyte-associated associated antigen
CD163,CD163,9332,M130 MM130 SCARI1,12p13.31,CD163 molecule,scavenger receptor cysteine-rich type 1 protein M130; hemoglobin scavenger receptor; macrophage-associated antigen
CD164,CD164,8763,DFNA66 MGC-24 MGC-24v MUC-24 endolyn,6q21,CD164 molecule,"sialomucin core protein 24; CD164 antigen, sialomucin; multi-glycosylated core protein 24"
CD165,CD165,23449,"-","-",CD165 antigen,CD165 antigen
CD166,ALCAM,214,CD166 MEMD,3q13.11,activated leukocyte cell adhesion molecule,CD166 antigen
CD167a,DDR1,780,CAK CD167 DDR EDDR1 HGK2 MCK10 NEP NTRK4 PTK3 PTK3A RTK6 TRKE,6p21.33,discoidin domain receptor tyrosine kinase 1,"epithelial discoidin domain-containing receptor 1; CD167 antigen-like family member A; PTK3A protein tyrosine kinase 3A; cell adhesion kinase; mammary carcinoma kinase 10; neuroepithelial tyrosine kinase; neurotrophic tyrosine kinase, receptor, type 4; protein-tyrosine kinase RTK-6; tyrosine kinase DDR; tyrosine-protein kinase CAK"
CD167b,DDR2,4921,MIG20a NTRKR3 TKT TYRO10,1q23.3,discoidin domain receptor tyrosine kinase 2,"discoidin domain-containing receptor 2; CD167 antigen-like family member B; cell migration-inducing protein 20; discoidin domain receptor 2; discoidin domain receptor family, member 2; discoidin domain-containing receptor tyrosine kinase 2; hydroxyaryl-protein kinase; migration-inducing gene 16 protein; neurotrophic tyrosine kinase receptor related 3; receptor protein-tyrosine kinase TKT; tyrosine-protein kinase TYRO10; tyrosylprotein kinase"
CD168,HMMR,3161,CD168 IHABP RHAMM,5q34,hyaluronan mediated motility receptor,hyaluronan mediated motility receptor; intracellular hyaluronic acid-binding protein; receptor for hyaluronan-mediated motility
CD169,SIGLEC1,6614,CD169 SIGLEC-1 SN dJ1009E24.1,20p13,sialic acid binding Ig like lectin 1,"sialoadhesin; sialic acid binding Ig-like lectin 1, sialoadhesin; sialic acid-binding immunoglobulin-like lectin 1"
CD170,SIGLEC5,8778,CD170 CD33L2 OB-BP2 OBBP2 SIGLEC-5,19q13.41,sialic acid binding Ig like lectin 5,sialic acid-binding Ig-like lectin 5; CD33 antigen-like 2; OB-binding protein 2; obesity-binding protein 2; sialic acid-binding immunoglobulin-like lectin 5
CD171,L1CAM,3897,CAML1 CD171 HSAS HSAS1 MASA MIC5 N-CAM-L1 N-CAML1 NCAM-L1 S10 SPG1,Xq28,L1 cell adhesion molecule,neural cell adhesion molecule L1; antigen identified by monoclonal antibody R1
CD172a,SIRPA,140885,BIT CD172A MFR MYD-1 P84 PTPNS1 SHPS1 SIRP,20p13,signal regulatory protein alpha,tyrosine-protein phosphatase non-receptor type substrate 1; CD172 antigen-like family member A; brain-immunoglobulin-like molecule with tyrosine-based activation motifs; inhibitory receptor SHPS-1; macrophage fusion receptor; myd-1 antigen; tyrosine phosphatase SHP substrate 1
CD172b,SIRPB1,10326,CD172b SIRP-BETA-1,20p13,signal regulatory protein beta 1,signal-regulatory protein beta-1; CD172 antigen-like family member B
CD172g,SIRPB2,284759,PTPN1L PTPNS1L3 dJ776F14.2,20p13,signal regulatory protein beta 2,"signal-regulatory protein beta-2; SIRP-beta-2; protein tyrosine phosphatase non-receptor type substrate protein; protein tyrosine phosphatase, non-receptor type substrate 1-like 3"
CD173,"-",-,-,-,-,-
CD174,FUT3,2525,CD174 FT3B FucT-III LE Les,19p13.3,fucosyltransferase 3 (Lewis blood group),"galactoside 3(4)-L-fucosyltransferase; Lewis FT; alpha-(1,3/1,4)-fucosyltransferase; blood group Lewis alpha-4-fucosyltransferase; fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group); fucosyltransferase III"
CD175,"-",-,-,-,-,-
CD175s,"-",-,-,-,-,-
CD176,"-",-,-,-,-,-
CD177,CD177,57126,HNA-2a HNA2A NB1 NB1 GP PRV-1 PRV1,19q13.31,CD177 molecule,CD177 antigen; NB1 glycoprotein; cell surface receptor; human neutrophil alloantigen 2a; polycythemia rubra vera protein 1
CD178,FASLG,356,ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 TNLG1A,1q24.3,Fas ligand,"tumor necrosis factor ligand superfamily member 6; CD95 ligand; Fas ligand (TNF superfamily, member 6); apoptosis (APO-1) antigen ligand 1; apoptosis antigen ligand; fas antigen ligand; mutant tumor necrosis factor family member 6; tumor necrosis factor ligand 1A"
CD179a,VPREB1,7441,CD179a IGI IGVPB VPREB,22q11.22,pre-B lymphocyte 1,immunoglobulin iota chain; CD179 antigen-like family member A; v(pre)B protein
CD179b,IGLL1,3543,14.1 AGM2 CD179b IGL1 IGL5 IGLJ14.1 IGLL IGO IGVPB VPREB2,22q11.23,immunoglobulin lambda like polypeptide 1,immunoglobulin lambda-like polypeptide 1; CD179 antigen-like family member B; CD179b antigen; Pre-B lymphocyte-specific protein-2; ig lambda-5; immunoglobulin omega polypeptide chain; immunoglobulin-related 14.1 protein; immunoglobulin-related protein 14.1; lambda5
CD180,CD180,4064,LY64 Ly78 RP105,5q12.3,CD180 molecule,"CD180 antigen; lymphocyte antigen 64; lymphocyte antigen-64, radioprotective, 105kDa; radioprotective 105 kDa protein"
CD181,CXCR1,3577,C-C C-C-CKR-1 CD128 CD181 CDw128a CKR-1 CMKAR1 IL8R1 IL8RA IL8RBA,2q35,C-X-C motif chemokine receptor 1,"C-X-C chemokine receptor type 1; CXC-R1; CXCR-1; IL-8 receptor type 1; IL-8R A; chemokine (C-X-C motif) receptor 1; high affinity interleukin-8 receptor A; interleukin 8 receptor, alpha; interleukin-8 receptor type 1; interleukin-8 receptor type A"
CD182,CXCR2,3579,CD182 CDw128b CMKAR2 IL8R2 IL8RA IL8RB,2q35,C-X-C motif chemokine receptor 2,"C-X-C chemokine receptor type 2; CXC-R2; CXCR-2; CXCR2 gene for IL8 receptor type B; GRO/MGSA receptor; IL-8 receptor type 2; IL-8R B; chemokine (CXC) receptor 2; high affinity interleukin-8 receptor B; interleukin 8 receptor type 2; interleukin 8 receptor, beta; interleukin-8 receptor type B"
CD183,CXCR3,2833,CD182 CD183 CKR-L2 CMKAR3 GPR9 IP10-R Mig-R MigR,Xq13.1,C-X-C motif chemokine receptor 3,C-X-C chemokine receptor type 3; G protein-coupled receptor 9; IP-10 receptor; Mig receptor; chemokine (C-X-C motif) receptor 3; chemokine receptor 3; interferon-inducible protein 10 receptor
CD184,CXCR4,7852,CD184 D2S201E FB22 HM89 HSY3RR LAP-3 LAP3 LCR1 LESTR NPY3R NPYR NPYRL NPYY3R WHIM WHIMS,2q22.1,C-X-C motif chemokine receptor 4,"C-X-C chemokine receptor type 4; CD184 antigen; LPS-associated protein 3; SDF-1 receptor; chemokine (C-X-C motif) receptor 4; chemokine receptor; fusin; leukocyte-derived seven transmembrane domain receptor; lipopolysaccharide-associated protein 3; neuropeptide Y receptor Y3; neuropeptide Y3 receptor; seven transmembrane helix receptor; seven-transmembrane-segment receptor, spleen; stromal cell-derived factor 1 receptor"
CD185,CXCR5,643,BLR1 CD185 MDR15,11q23.3,C-X-C motif chemokine receptor 5,"C-X-C chemokine receptor type 5; Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5); Burkitt lymphoma receptor 1, GTP-binding protein; CXC-R5; CXCR-5; MDR-15; chemokine (C-X-C motif) receptor 5; monocyte-derived receptor 15"
CD186,CXCR6,10663,BONZO CD186 STRL33 TYMSTR,3p21.31,C-X-C motif chemokine receptor 6,C-X-C chemokine receptor type 6; CDw186; CXC-R6; CXCR-6; G protein-coupled receptor; G-protein coupled receptor STRL33; G-protein coupled receptor bonzo; chemokine (C-X-C motif) receptor 6
CD191,CCR1,1230,CD191 CKR-1 CKR1 CMKBR1 HM145 MIP1aR SCYAR1,3p21.31,C-C motif chemokine receptor 1,C-C chemokine receptor type 1; C-C CKR-1; CC-CKR-1; CCR-1; LD78 receptor; MIP-1alpha-R; RANTES receptor; RANTES-R; chemokine (C-C motif) receptor 1; macrophage inflammatory protein 1-alpha receptor
CD192,CCR2,729230,CC-CKR-2 CCR-2 CCR2A CCR2B CD192 CKR2 CKR2A CKR2B CMKBR2 MCP-1-R,3p21.31,C-C motif chemokine receptor 2,C-C chemokine receptor type 2; MCP-1 receptor; chemokine (C-C motif) receptor 2; monocyte chemoattractant protein 1 receptor; monocyte chemotactic protein 1 receptor
CD193,CCR3,1232,CC-CKR-3 CD193 CKR3 CMKBR3,3p21.31,C-C motif chemokine receptor 3,C-C chemokine receptor type 3; C-C CKR-3; CC chemokine receptor 3; CCR-3; b-chemokine receptor; chemokine (C-C motif) receptor 3; eosinophil CC chemokine receptor 3; eosinophil eotaxin receptor
CD194,CCR4,1233,CC-CKR-4 CD194 CKR4 CMKBR4 ChemR13 HGCN:14099 K5-5,3p22.3,C-C motif chemokine receptor 4,C-C chemokine receptor type 4; C-C CKR-4; CCR-4; chemokine (C-C motif) receptor 4; chemokine (C-C) receptor 4
CD195,CCR5,1234,CC-CKR-5 CCCKR5 CCR-5 CD195 CKR-5 CKR5 CMKBR5 IDDM22,3p21.31,C-C motif chemokine receptor 5 (gene/pseudogene),C-C chemokine receptor type 5; C-C motif chemokine receptor 5 A159A; HIV-1 fusion coreceptor; chemokine (C-C motif) receptor 5; chemokine receptor CCR5; chemr13
CD196,CCR6,1235,BN-1 C-C CKR-6 CC-CKR-6 CCR-6 CD196 CKR-L3 CKRL3 CMKBR6 DCR2 DRY6 GPR29 GPRCY4 STRL22,6q27,C-C motif chemokine receptor 6,"C-C chemokine receptor type 6; G protein-coupled receptor 29; LARC receptor; chemokine (C-C motif) receptor 6; chemokine (C-C) receptor 6; chemokine receptor-like 3; seven-transmembrane receptor, lymphocyte, 22"
CD197,CCR7,1236,BLR2 CC-CKR-7 CCR-7 CD197 CDw197 CMKBR7 EBI1,17q21.2,C-C motif chemokine receptor 7,C-C chemokine receptor type 7; Bukitt's lymphoma receptor 2; CC chemokine receptor 7; EBV-induced G protein-coupled receptor 1; Epstein-Barr virus induced gene 1; Epstein-Barr virus-induced G-protein coupled receptor 1; MIP-3 beta receptor; chemokine (C-C motif) receptor 7; lymphocyte-specific G protein-coupled peptide receptor
CD198,CCR8,1237,CC-CKR-8 CCR-8 CDw198 CKRL1 CMKBR8 CMKBRL2 CY6 GPRCY6 TER1,3p22.1,C-C motif chemokine receptor 8,C-C chemokine receptor type 8; CC chemokine receptor 8; CC chemokine receptor CHEMR1; CC-chemokine receptor chemr1; chemokine (C-C motif) receptor 8; chemokine (C-C) receptor 8; chemokine (C-C) receptor-like 2; chemokine receptor-like 1
CD199,CCR9,10803,CC-CKR-9 CDw199 GPR-9-6 GPR28,3p21.31,C-C motif chemokine receptor 9,C-C chemokine receptor type 9; G protein-coupled receptor 28; chemokine (C-C motif) receptor 9
CD200,CD200,4345,MOX1 MOX2 MRC OX-2,3q13.2,CD200 molecule,OX-2 membrane glycoprotein; CD200 antigen; antigen identified by monoclonal antibody MRC OX-2
CD201,PROCR,10544,CCCA CCD41 EPCR,20q11.22,protein C receptor,"endothelial protein C receptor; APC receptor; CD201 antigen; activated protein C receptor; cell cycle, centrosome-associated protein; centrocyclin; protein C receptor, endothelial"
CD202b,TEK,7010,CD202B GLC3E TIE-2 TIE2 VMCM VMCM1,9p21.2,TEK receptor tyrosine kinase,"angiopoietin-1 receptor; TEK tyrosine kinase, endothelial; endothelial tyrosine kinase; tunica interna endothelial cell kinase; tyrosine kinase with Ig and EGF homology domains-2; tyrosine-protein kinase receptor TEK; tyrosine-protein kinase receptor TIE-2"
CD203c,ENPP3,5169,B10 CD203c NPP3 PD-IBETA PDNP3,6q23.2,ectonucleotide pyrophosphatase/phosphodiesterase 3,ectonucleotide pyrophosphatase/phosphodiesterase family member 3; dJ1005H11.3 (phosphodiesterase I/nucleotide pyrophosphatase 3); dJ914N13.3 (phosphodiesterase I/nucleotide pyrophosphatase 3); gp130RB13-6; phosphodiesterase I/nucleotide pyrophosphatase 3; phosphodiesterase-I beta
CD204,MSR1,4481,CD204 SCARA1 SR-A SR-AI SR-AII SR-AIII SRA phSR1 phSR2,8p22,macrophage scavenger receptor 1,macrophage scavenger receptor types I and II; macrophage acetylated LDL receptor I and II; macrophage scavenger receptor type III; scavenger receptor class A member 1
CD205,LY75,4065,CD205 CLEC13B DEC-205 GP200-MR6 LY-75,2q24.2,lymphocyte antigen 75,lymphocyte antigen 75; C-type lectin domain family 13 member B
CD206,MRC1,4360,CD206 CLEC13D CLEC13DL MMR MRC1L1 bA541I19.1 hMR,10p12.33,mannose receptor C-type 1,"macrophage mannose receptor 1; C-type lectin domain family 13 member D; human mannose receptor; macrophage mannose receptor 1-like protein 1; mannose receptor, C type 1-like 1"
CD207,CD207,50489,CLEC4K,2p13.3,CD207 molecule,"C-type lectin domain family 4 member K; C-type lectin domain family 4, member K; CD207 antigen, langerin; CD207 molecule, langerin; Langerhans cell specific c-type lectin"
CD208,LAMP3,27074,CD208 DC LAMP DC-LAMP DCLAMP LAMP LAMP-3 TSC403,3q27.1,lysosomal associated membrane protein 3,lysosome-associated membrane glycoprotein 3; DC-lysosome-associated membrane glycoprotein
CD209,CD209,30835,CDSIGN CLEC4L DC-SIGN DC-SIGN1,19p13.2,CD209 molecule,CD209 antigen; C-type lectin domain family 4 member L; HIV gpl20-binding protein; dendritic cell-specific ICAM-3-grabbing non-integrin 1; dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin; dendritic cell-specific intracellular adhesion molecules (ICAM)-3 grabbing non-integrin
CD210a,IL10RA,3587,CD210 CD210a CDW210A HIL-10R IL-10R1 IL10R,11q23.3,interleukin 10 receptor subunit alpha,"interleukin-10 receptor subunit alpha; IL-10 receptor subunit alpha; IL-10R subunit 1; IL-10R subunit alpha; IL-10RA; interleukin 10 receptor, alpha; interleukin-10 receptor alpha chain; interleukin-10 receptor subunit 1"
CD210b,IL10RB,3588,CDW210B CRF2-4 CRFB4 D21S58 D21S66 IL-10R2,21q22.11,interleukin 10 receptor subunit beta,"interleukin-10 receptor subunit beta; IL-10 receptor subunit beta; IL-10R subunit 2; IL-10R subunit beta; IL-10RB; cytokine receptor class-II CRF2-4; cytokine receptor class-II member 4; cytokine receptor family 2 member 4; cytokine receptor family II, member 4; interleukin 10 receptor, beta; interleukin-10 receptor subunit 2"
CD212,IL12RB1,3594,CD212 IL-12R-BETA1 IL12RB IMD30,19p13.11,interleukin 12 receptor subunit beta 1,"interleukin-12 receptor subunit beta-1; IL-12 receptor beta component; IL-12 receptor subunit beta-1; IL-12R subunit beta-1; cluster of differentiation 212; interleukin 12 receptor, beta 1; interleukin-12 receptor beta-1 chain"
CD213a1,IL13RA1,3597,CD213A1 CT19 IL-13Ra NR4,Xq24,interleukin 13 receptor subunit alpha 1,"interleukin-13 receptor subunit alpha-1; CD213a1 antigen; IL-13 receptor subunit alpha-1; IL-13R subunit alpha-1; IL13 receptor alpha-1 chain; cancer/testis antigen 19; interleukin 13 receptor, alpha 1"
CD213a2,IL13RA2,3598,CD213A2 CT19 IL-13R IL13BP,Xq23,interleukin 13 receptor subunit alpha 2,"interleukin-13 receptor subunit alpha-2; IL-13 receptor subunit alpha-2; IL-13R subunit alpha-2; IL-13R-alpha-2; IL-13RA2; cancer/testis antigen 19; interleukin 13 binding protein; interleukin 13 receptor alpha 2 chain; interleukin 13 receptor, alpha 2"
CD215,IL15RA,3601,CD215,10p15.1,interleukin 15 receptor subunit alpha,"interleukin-15 receptor subunit alpha; interleukin 15 receptor alpha isoform EM2; interleukin 15 receptor alpha isoform IC2; interleukin 15 receptor alpha isoform IC3; interleukin 15 receptor alpha isoform IC4; interleukin 15 receptor alpha isoform IC5; interleukin 15 receptor alpha isoform IC6; interleukin 15 receptor alpha isoform IC7; interleukin 15 receptor alpha isoform IC8; interleukin 15 receptor, alpha"
CD217,IL17RA,23765,CANDF5 CD217 CDw217 IL-17RA IL17R IMD51 hIL-17R,22q11.1,interleukin 17 receptor A,interleukin-17 receptor A; IL-17 receptor A
CD218a,IL18R1,8809,CD218a CDw218a IL-1Rrp IL18RA IL1RRP,2q12.1,interleukin 18 receptor 1,interleukin-18 receptor 1; CD218 antigen-like family member A; IL-18R-1; IL-18R1; IL1 receptor-related protein; IL18Ralpha2; IL1R-rp; cytokine receptor
CD218b,IL18RAP,8807,ACPL CD218b CDw218b IL-18R-beta IL-18RAcP IL-18Rbeta IL-1R-7 IL-1R7 IL-1RAcPL IL18RB,2q12.1,interleukin 18 receptor accessory protein,interleukin-18 receptor accessory protein; CD218 antigen-like family member B; IL-18 receptor accessory protein; IL-18 receptor beta; cluster of differentiation w218b; interleukin-1 receptor 7; interleukin-18 receptor beta
CD220,INSR,3643,CD220 HHF5,19p13.2,insulin receptor,insulin receptor; IR
CD221,IGF1R,3480,CD221 IGFIR IGFR JTK13,15q26.3,insulin like growth factor 1 receptor,insulin-like growth factor 1 receptor; IGF-I receptor; soluble IGF1R variant 1; soluble IGF1R variant 2
CD222,IGF2R,3482,CD222 CI-M6PR CIMPR M6P-R M6P/IGF2R MPR 300 MPR1 MPR300 MPRI,6q25.3,insulin like growth factor 2 receptor,cation-independent mannose-6-phosphate receptor; 300 kDa mannose 6-phosphate receptor; CI Man-6-P receptor; IGF-II receptor; M6P/IGF2 receptor; insulin-like growth factor II receptor
CD223,LAG3,3902,CD223,12p13.31,lymphocyte activating 3,lymphocyte activation gene 3 protein; lymphocyte-activation gene 3
CD224,GGT1,2678,CD224 D22S672 D22S732 GGT GGT 1 GTG,22q11.23,gamma-glutamyltransferase 1,gamma-glutamyltranspeptidase 1; glutathione hydrolase 1; leukotriene-C4 hydrolase; testicular tissue protein Li 73
CD225,IFITM1,8519,9-27 CD225 DSPA2a IFI17 LEU13,11p15.5,interferon induced transmembrane protein 1,interferon-induced transmembrane protein 1; dispanin subfamily A member 2a; interferon-induced protein 17; interferon-inducible protein 9-27; leu-13 antigen
CD226,CD226,10666,DNAM-1 DNAM1 PTA1 TLiSA1,18q22.2,CD226 molecule,CD226 antigen; DNAX accessory molecule-1; T lineage-specific activation antigen 1 antigen; adhesion glycoprotein; platelet and T cell activation antigen 1
CD227,MUC1,4582,ADMCKD ADMCKD1 CA 15-3 CD227 EMA H23AG KL-6 MAM6 MCD MCKD MCKD1 MUC-1 MUC-1/SEC MUC-1/X MUC1/ZD PEM PEMT PUM,1q22,"mucin 1, cell surface associated","mucin-1; H23 antigen; breast carcinoma-associated antigen DF3; cancer antigen 15-3; carcinoma-associated mucin; episialin; krebs von den Lungen-6; mucin 1, transmembrane; peanut-reactive urinary mucin; polymorphic epithelial mucin; tumor associated epithelial mucin; tumor-associated epithelial membrane antigen"
CD228,MELTF,4241,CD228 MAP97 MFI2 MTF1 MTf,3q29,melanotransferrin,melanotransferrin; antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5; melanoma-associated antigen p97; membrane-bound transferrin-like protein
CD229,LY9,4063,CD229 SLAMF3 hly9 mLY9,1q23.3,lymphocyte antigen 9,T-lymphocyte surface antigen Ly-9; SLAM family member 3; cell surface molecule Ly-9; signaling lymphocytic activation molecule 3
CD230,PRNP,5621,ASCR AltPrP CD230 CJD GSS KURU PRIP PrP PrP27-30 PrP33-35C PrPc p27-30,20p13,prion protein,major prion protein; alternative prion protein; CD230 antigen; prion-related protein
CD231,TSPAN7,7102,A15 CCG-B7 CD231 DXS1692E MRX58 MXS1 TALLA-1 TM4SF2 TM4SF2b,Xp11.4,tetraspanin 7,"tetraspanin-7; CD231 antigen; T-cell acute lymphoblastic leukemia associated antigen 1; cell surface glycoprotein A15; membrane component chromosome X surface marker 1; membrane component, X chromosome, surface marker 1; tetraspanin protein; transmembrane 4 superfamily 2b; transmembrane 4 superfamily member 2; transmembrane protein A15; tspan-7"
CD232,PLXNC1,10154,CD232 PLXN-C1 VESPR,12q22,plexin C1,plexin-C1; plexin (semaphorin receptor); receptor for viral semaphorin protein; receptor for virally-encoded semaphorin; virus-encoded semaphorin protein receptor
CD233,SLC4A1,6521,AE1 BND3 CD233 CHC DI EMPB3 EPB3 FR RTA1A SAO SPH4 SW WD WD1 WR,17q21.31,solute carrier family 4 member 1 (Diego blood group),"band 3 anion transport protein; Diego blood group; Froese blood group; Swann blood group; Waldner blood group; Wright blood group; anion exchange protein 1; anion exchanger-1; erythrocyte membrane protein band 3; erythroid anion exchange protein; solute carrier family 4 (anion exchanger), member 1 (Diego blood group); solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group); solute carrier family 4, anion exchanger, number 1"
CD234,ACKR1,2532,CCBP1 CD234 DARC DARC/ACKR1 Dfy FY GPD GpFy WBCQ1,1q23.2,atypical chemokine receptor 1 (Duffy blood group),"atypical chemokine receptor 1; Duffy antigen chemokine receptor; Duffy blood group antigen; Duffy blood group system protein; Duffy blood group, chemokine receptor; Fy glycoprotein; glycoprotein D; plasmodium vivax receptor"
CD235a,GYPA,2993,CD235a GPA GPErik GPSAT HGpMiV HGpMiXI HGpSta(C) MN MNS PAS-2,4q31.21,glycophorin A (MNS blood group),"glycophorin-A; MN sialoglycoprotein; Mi.V glycoprotein (24 AA); erythroid-lineage-specific membrane sialoglycoprotein; glycophorin A (MN blood group); glycophorin A, GPA; glycophorin Erik; glycophorin MiI; glycophorin MiV; glycophorin SAT; glycophorin Sta type C; recombinant glycophorin A-B Miltenberger-DR; sialoglycoprotein alpha"
CD235b,GYPB,2994,CD235b GPB GYP MNS PAS-3 SS,4q31.21,glycophorin B (MNS blood group),"glycophorin-B; GYPB-A fusion; GYPB-A-B fusion; GYPB/GYPA fusion; SS-active sialoglycoprotein; Ss blood group; blood group system MNSs, Mur-like; blood group system MNSs, St(a) type E; blood group system MNSs, St(a) type F; glycophorin B, blood group system Ss, S, Mit+; glycophorin B/glycophorin A fusion protein; glycophorin Hop; hybrid glycophorin Kip; sialoglycoprotein delta"
CD236,GYPC,2995,CD236 CD236R GE GE:GPC:GPD:GYPD GPC GPD GYPD PAS-2 PAS-2',2q14.3,glycophorin C (Gerbich blood group),glycophorin-C; glycoconnectin; glycophorin-D; glycoprotein beta; sialoglycoprotein D
CD238,KEL,3792,CD238 ECE3,7q34,"Kell blood group, metallo-endopeptidase",kell blood group glycoprotein; kell blood group antigen
CD239,BCAM,4059,AU CD239 LU MSK19,19q13.32,basal cell adhesion molecule (Lutheran blood group),basal cell adhesion molecule; Auberger b antigen; B-CAM cell surface glycoprotein; B-cell adhesion molecule; F8/G253 antigen; Lutheran blood group variant LUGA; basal cell adhesion molecule (Lu and Au blood groups)
CD240CE,RHCE,6006,CD240CE RH RH30A RHC RHCe(152N) RHE RHIXB RHPI Rh4 RhIVb(J) RhVI RhVIII,1p36.11,Rh blood group CcEe antigens,"blood group Rh(CE) polypeptide; (C)ces type 1 Rhesus blood group D antigen; RHCE blood group variant Crawford antigen Rh43; Rh blood group C antigen; Rh blood group CE antigen; Rh blood group CcEe antigen; Rh blood group antigen Evans; Rh blood group protein; Rh polypeptide I; RhCE blood group antigens; Rhesus blood group CE protein; Rhesus blood group E antigen; Rhesus blood group Rhce antigen; Rhesus system C and E polypeptides; blood group RhCE polypeptide; blood group RhCcEe antigen; rh polypeptide 1; rhesus C/E antigens; rhesus blood group antigen, RhC antigen; rhesus blood group little e antigen; silenced Rh blood group CcEe antigen; truncated RHCE; truncated RhCcEe antigen"
CD240D,RHD,6007,CD240D DIIIc RH RH30 RHCED RHDVA(TT) RHDel RHPII RHXIII Rh4 RhDCw RhII RhK562-II RhPI,1p36.11,Rh blood group D antigen,"blood group Rh(D) polypeptide; D antigen (DCS); RH polypeptide 2; Rh blood group C antigen; Rh blood group CE antigen; Rh blood group CcEe antigen; Rh blood group antigen Evans; Rh blood group, D anitgen; RhD blood group antigen; RhD polypeptide; Rhesus blood group D antigen allele DIII type 7; Rhesus system D polypeptide; blood group antigen D; blood group protein RHD; rhesus D antigen; truncated Rh blood group D antigen; truncated RhD; truncated rhesus D; truncated rhesus blood group D antigen"
CD241,RHAG,6005,CD241 OHS OHST RH2 RH50A Rh50 Rh50GP SLC42A1,6p12.3,Rh-associated glycoprotein,"ammonium transporter Rh type A; Rh 50 glycoprotein; Rhesus associated polypeptide, 50-KD; Rhesus blood group-associated glycoprotein; erythrocyte membrane glycoprotein Rh50; erythrocyte plasma membrane 50 kDa glycoprotein; rh family type A glycoprotein; rh type A glycoprotein; rhesus blood group family type A glycoprotein; rhesus blood group-associated ammonia channel; truncated Rh-associated glycoprotein"
CD242,ICAM4,3386,CD242 LW,19p13.2,intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),intercellular adhesion molecule 4; CD242 antigen; LW antigen a; Landsteiner-Wiener blood group antigen a; Landsteiner-Wiener blood group glycoprotein; intercellular adhesion molecule 4 (LW blood group)
CD243,ABCB1,5243,ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1,7q21.12,ATP binding cassette subfamily B member 1,"multidrug resistance protein 1; ATP-binding cassette, sub-family B (MDR/TAP), member 1; P glycoprotein; P-glycoprotein 1; colchicin sensitivity; doxorubicin resistance"
CD244,CD244,51744,2B4 NAIL NKR2B4 Nmrk SLAMF4,1q23.3,CD244 molecule,"natural killer cell receptor 2B4; CD244 molecule, natural killer cell receptor 2B4; NK cell activation inducing ligand NAIL; NK cell activation-inducing ligand; NK cell type I receptor protein 2B4; SLAM family member 4; h2B4; signaling lymphocytic activation molecule 4"
CD246,ALK,238,CD246 NBLST3,2p23.2-p23.1,ALK receptor tyrosine kinase,ALK tyrosine kinase receptor; CD246 antigen; anaplastic lymphoma receptor tyrosine kinase; mutant anaplastic lymphoma kinase
CD247,CD247,919,CD3-ZETA CD3H CD3Q CD3Z IMD25 T3Z TCRZ,1q24.2,CD247 molecule,"T-cell surface glycoprotein CD3 zeta chain; CD247 antigen, zeta subunit; CD3Z antigen, zeta polypeptide (TiT3 complex); CD3zeta chain; T-cell antigen receptor complex, zeta subunit of CD3; T-cell receptor T3 zeta chain; TCR zeta chain"
CD248,CD248,57124,CD164L1 TEM1,11q13.2,CD248 molecule,"endosialin; 2610111G01Rik; CD164 sialomucin-like 1; CD248 antigen, endosialin; CD248 molecule, endosialin; tumor endothelial marker 1"
CD249,ENPEP,2028,APA CD249 gp160,4q25,glutamyl aminopeptidase,glutamyl aminopeptidase; AP-A; EAP; aminopeptidase A; differentiation antigen gp160
CD252,TNFSF4,7292,CD134L CD252 GP34 OX-40L OX4OL TNLG2B TXGP1,1q25.1,TNF superfamily member 4,tumor necrosis factor ligand superfamily member 4; CD134 ligand; OX40 antigen ligand; glycoprotein Gp34; tax-transcriptionally activated glycoprotein 1 (34kD); tumor necrosis factor (ligand) superfamily member 4; tumor necrosis factor ligand 2B; tumor necrosis factor superfamily member 4
CD253,TNFSF10,8743,APO2L Apo-2L CD253 TL2 TNLG6A TRAIL,3q26.31,TNF superfamily member 10,"tumor necrosis factor ligand superfamily member 10; Apo-2 ligand; TNF-related apoptosis inducing ligand TRAIL; chemokine tumor necrosis factor ligand superfamily member 10; tumor necrosis factor (ligand) family, member 10; tumor necrosis factor (ligand) superfamily, member 10; tumor necrosis factor apoptosis-inducing ligand splice variant delta; tumor necrosis factor ligand 6A; tumor necrosis factor superfamily member 10"
CD254,TNFSF11,8600,CD254 ODF OPGL OPTB2 RANKL TNLG6B TRANCE hRANKL2 sOdf,13q14.11,TNF superfamily member 11,"tumor necrosis factor ligand superfamily member 11; TNF-related activation-induced cytokine; osteoclast differentiation factor; osteoprotegerin ligand; receptor activator of nuclear factor kappa B ligand; tumor necrosis factor (ligand) superfamily, member 11; tumor necrosis factor ligand 6B; tumor necrosis factor superfamily member 11"
CD256,TNFSF13,8741,APRIL CD256 TALL-2 TALL2 TNLG7B TRDL-1 UNQ383/PRO715 ZTNF2,17p13.1,TNF superfamily member 13,"tumor necrosis factor ligand superfamily member 13; TNF- and APOL-related leukocyte expressed ligand 2; a proliferation-inducing ligand; tumor necrosis factor (ligand) superfamily, member 13; tumor necrosis factor ligand 7B; tumor necrosis factor superfamily member 13; tumor necrosis factor-like protein ZTNF2; tumor necrosis factor-related death ligand-1"
CD257,TNFSF13B,10673,BAFF BLYS CD257 DTL TALL-1 TALL1 THANK TNFSF20 TNLG7A ZTNF4,13q33.3,TNF superfamily member 13b,"tumor necrosis factor ligand superfamily member 13B; ApoL related ligand TALL-1; B-cell-activating factor; B-lymphocyte stimulator; Delta4 BAFF; TNF and ApoL-related leukocyte expressed ligand 1; TNF homolog that activates apoptosis; delta BAFF; dendritic cell-derived TNF-like molecule; tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor (ligand) superfamily, member 20; tumor necrosis factor ligand 7A; tumor necrosis factor superfamily member 13b; tumor necrosis factor-like protein ZTNF4"
CD258,TNFSF14,8740,CD258 HVEML LIGHT LTg,19p13.3,TNF superfamily member 14,"tumor necrosis factor ligand superfamily member 14; herpesvirus entry mediator ligand; tumor necrosis factor (ligand) superfamily, member 14; tumor necrosis factor ligand 1D; tumor necrosis factor superfamily member 14"
CD261,TNFRSF10A,8797,APO2 CD261 DR4 TRAILR-1 TRAILR1,8p21.3,TNF receptor superfamily member 10a,"tumor necrosis factor receptor superfamily member 10A; TNF-related apoptosis-inducing ligand receptor 1; TRAIL receptor 1; TRAIL-R1; cytotoxic TRAIL receptor; death receptor 4; tumor necrosis factor receptor superfamily member 10a variant 2; tumor necrosis factor receptor superfamily, member 10a"
CD262,TNFRSF10B,8795,CD262 DR5 KILLER KILLER/DR5 TRAIL-R2 TRAILR2 TRICK2 TRICK2A TRICK2B TRICKB ZTNFR9,8p21.3,TNF receptor superfamily member 10b,"tumor necrosis factor receptor superfamily member 10B; Fas-like protein; TNF-related apoptosis-inducing ligand receptor 2; apoptosis inducing protein TRICK2A/2B; apoptosis inducing receptor TRAIL-R2; cytotoxic TRAIL receptor-2; death domain containing receptor for TRAIL/Apo-2L; death receptor 5; p53-regulated DNA damage-inducible cell death receptor(killer); tumor necrosis factor receptor superfamily, member 10b; tumor necrosis factor receptor-like protein ZTNFR9"
CD263,TNFRSF10C,8794,CD263 DCR1 DCR1-TNFR LIT TRAIL-R3 TRAILR3 TRID,8p21.3,TNF receptor superfamily member 10c,"tumor necrosis factor receptor superfamily member 10C; TNF-related apoptosis-inducing ligand receptor 3; antagonist decoy receptor for TRAIL/Apo-2L; cytotoxic TRAIL receptor-3; decoy TRAIL receptor without death domain; decoy receptor 1; lymphocyte inhibitor of TRAIL; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain"
CD264,TNFRSF10D,8793,CD264 DCR2 TRAIL-R4 TRAILR4 TRUNDD,8p21.3,TNF receptor superfamily member 10d,"tumor necrosis factor receptor superfamily member 10D; TNF receptor-related receptor for TRAIL; TNF-related apoptosis-inducing ligand receptor 4; TRAIL receptor 4; TRAIL receptor with a truncated death domain; decoy receptor 2; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain"
CD265,TNFRSF11A,8792,CD265 FEO LOH18CR1 ODFR OFE OPTB7 OSTS PDB2 RANK TRANCER,18q21.33,TNF receptor superfamily member 11a,"tumor necrosis factor receptor superfamily member 11A; Paget disease of bone 2; loss of heterozygosity, 18, chromosomal region 1; osteoclast differentiation factor receptor; receptor activator of NF-KB; receptor activator of nuclear factor-kappa B; tumor necrosis factor receptor superfamily, member 11a, NFKB activator"
CD266,TNFRSF12A,51330,CD266 FN14 TWEAKR,16p13.3,TNF receptor superfamily member 12A,tumor necrosis factor receptor superfamily member 12A; FGF-inducible 14; fibroblast growth factor-inducible immediate-early response protein 14; tweak-receptor; type I transmembrane protein Fn14
CD267,TNFRSF13B,23495,CD267 CVID CVID2 IGAD2 RYZN TACI TNFRSF14B,17p11.2,TNF receptor superfamily member 13B,tumor necrosis factor receptor superfamily member 13B; transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B
CD268,TNFRSF13C,115650,BAFF-R BAFFR BROMIX CD268 CVID4 prolixin,22q13.2,TNF receptor superfamily member 13C,tumor necrosis factor receptor superfamily member 13C; B cell-activating factor receptor; BAFF receptor; BLyS receptor 3
CD269,TNFRSF17,608,BCM BCMA CD269 TNFRSF13A,16p13.13,TNF receptor superfamily member 17,tumor necrosis factor receptor superfamily member 17; B cell maturation antigen; B-cell maturation factor; B-cell maturation protein
CD270,TNFRSF14,8764,ATAR CD270 HVEA HVEM LIGHTR TR2,1p36.32,TNF receptor superfamily member 14,"tumor necrosis factor receptor superfamily member 14; CD40-like protein; herpes virus entry mediator A; tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator); tumor necrosis factor receptor-like gene2"
CD271,NGFR,4804,CD271 Gp80-LNGFR TNFRSF16 p75(NTR) p75NTR,17q21.33,nerve growth factor receptor,"tumor necrosis factor receptor superfamily member 16; NGF receptor; TNFR superfamily, member 16; low affinity neurotrophin receptor p75NTR; low-affinity nerve growth factor receptor; p75 ICD"
CD272,BTLA,151888,BTLA1 CD272,3q13.2,B and T lymphocyte associated,B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein
CD273,PDCD1LG2,80380,B7DC Btdc CD273 PD-L2 PDCD1L2 PDL2 bA574F11.2,9p24.1,programmed cell death 1 ligand 2,programmed cell death 1 ligand 2; B7 dendritic cell molecule; B7-DC; PD-1-ligand 2; PDCD1 ligand 2; butyrophilin B7-DC; programmed death ligand 2
CD274,CD274,29126,B7-H B7H1 PD-L1 PDCD1L1 PDCD1LG1 PDL1,9p24.1,CD274 molecule,programmed cell death 1 ligand 1; B7 homolog 1; CD274 antigen; PDCD1 ligand 1
CD275,ICOSLG,23308,B7-H2 B7H2 B7RP-1 B7RP1 CD275 GL50 ICOS-L ICOSL LICOS,21q22.3,inducible T-cell costimulator ligand,ICOS ligand; B7 homolog 2; B7 homologue 2; B7-like protein Gl50; B7-related protein 1; inducible T-cell co-stimulator ligand; transmembrane protein B7-H2 ICOS ligand
CD276,CD276,80381,4Ig-B7-H3 B7-H3 B7H3 B7RP-2,15q24.1,CD276 molecule,CD276 antigen; B7 homolog 3; costimulatory molecule
CD277,BTN3A1,11119,BT3.1 BTF5 BTN3.1 CD277,6p22.2,butyrophilin subfamily 3 member A1,"butyrophilin subfamily 3 member A1; dJ45P21.3 (butyrophilin, subfamily 3, member A1)"
CD278,ICOS,29851,AILIM CD278 CVID1,2q33.2,inducible T-cell costimulator,inducible T-cell costimulator; activation-inducible lymphocyte immunomediatory molecule; inducible T-cell co-stimulator; inducible costimulator
CD279,PDCD1,5133,CD279 PD-1 PD1 SLEB2 hPD-1 hPD-l hSLE1,2q37.3,programmed cell death 1,programmed cell death protein 1; programmed cell death 1 protein; protein PD-1; systemic lupus erythematosus susceptibility 2
CD280,MRC2,9902,CD280 CLEC13E ENDO180 UPARAP,17q23.2,mannose receptor C type 2,C-type mannose receptor 2; C-type lectin domain family 13 member E; UPAR-associated protein; endocytic receptor (macrophage mannose receptor family); endocytic receptor 180; macrophage mannose receptor 2; urokinase-type plasminogen activator receptor-associated protein
CD281,TLR1,7096,CD281 TIL TIL. LPRS5 rsc786,4p14,toll like receptor 1,toll-like receptor 1; toll/interleukin-1 receptor-like protein
CD282,TLR2,7097,CD282 TIL4,4q31.3,toll like receptor 2,toll-like receptor 2; toll/interleukin-1 receptor-like protein 4
CD283,TLR3,7098,CD283 IIAE2,4q35.1,toll like receptor 3,toll-like receptor 3
CD284,TLR4,7099,ARMD10 CD284 TLR-4 TOLL,9q33.1,toll like receptor 4,toll-like receptor 4; hToll; homolog of Drosophila toll
CD286,TLR6,10333,CD286,4p14,toll like receptor 6,toll-like receptor 6
CD288,TLR8,51311,CD288,Xp22.2,toll like receptor 8,toll-like receptor 8
CD289,TLR9,54106,CD289,3p21.2,toll like receptor 9,toll-like receptor 9
CD290,TLR10,81793,CD290,4p14,toll like receptor 10,toll-like receptor 10
CD292,BMPR1A,657,10q23del ACVRLK3 ALK3 CD292 SKR5,10q23.2,bone morphogenetic protein receptor type 1A,"bone morphogenetic protein receptor type-1A; ALK-3; BMP type-1A receptor; BMPR-1A; activin A receptor, type II-like kinase 3; activin receptor-like kinase 3; bone morphogenetic protein receptor, type IA; serine/threonine-protein kinase receptor R5"
CD293,BMPR1B,658,ALK-6 ALK6 AMDD BDA1D BDA2 CDw293,4q22.3,bone morphogenetic protein receptor type 1B,"bone morphogenetic protein receptor type-1B; BMP type-1B receptor; BMPR-1B; activin receptor-like kinase 6; bone morphogenetic protein receptor, type IB; serine/threonine receptor kinase"
CD294,PTGDR2,11251,CD294 CRTH2 DL1R DP2 GPR44,11q12.2,prostaglandin D2 receptor 2,prostaglandin D2 receptor 2; G-protein coupled receptor 44; chemoattractant receptor homologous molecule expressed on T helper type 2 cells; chemoattractant receptor-homologous molecule expressed on TH2 cells; putative G-protein coupled receptor 44
CD295,LEPR,3953,CD295 LEP-R LEPRD OB-R OBR,1p31.3,leptin receptor,leptin receptor; OB receptor; huB219
CD296,ART1,417,ART2 ARTC1 CD296 RT6,11p15.4,ADP-ribosyltransferase 1,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1; ADP-ribosyltransferase 2; ADP-ribosyltransferase C2 and C3 toxin-like 1; mono(ADP-ribosyl)transferase 1
CD297,ART4,420,ARTC4 CD297 DO DOK1,12p12.3,ADP-ribosyltransferase 4 (Dombrock blood group),ecto-ADP-ribosyltransferase 4; ADP-ribosyltransferase 4 (DO blood group); ADP-ribosyltransferase C2 and C3 toxin-like 4; Dombrock blood group carrier molecule; NAD(+)--protein-arginine ADP-ribosyltransferase 4; NAD(P)(+)--arginine ADP-ribosyltransferase 4; mono-ADP-ribosyltransferase 4
CD298,ATP1B3,483,ATPB-3 CD298,3q23,ATPase Na+/K+ transporting subunit beta 3,"sodium/potassium-transporting ATPase subunit beta-3; ATPase, Na+/K+ transporting, beta 3 polypeptide; Na, K-ATPase beta-3 polypeptide; sodium pump subunit beta-3; sodium-potassium ATPase subunit beta 3 (non-catalytic); sodium/potassium-dependent ATPase subunit beta-3; sodium/potassium-transporting ATPase beta-3 chain"
CD299,CLEC4M,10332,CD209L CD299 DC-SIGN2 DC-SIGNR DCSIGNR HP10347 L-SIGN LSIGN,19p13.2,C-type lectin domain family 4 member M,C-type lectin domain family 4 member M; CD209 antigen-like protein 1; CD299 antigen; DC-SIGN-related protein; dendritic cell-specific ICAM-3-grabbing non-integrin 2; liver/lymph node-specific ICAM-3 grabbing non-integrin; mannose binding C-type lectin DC-SIGNR
CD300a,CD300A,11314,CLM-8 CMRF-35-H9 CMRF-35H CMRF35-H CMRF35-H9 CMRF35H CMRF35H9 IGSF12 IRC1 IRC1/IRC2 IRC2 IRp60,17q25.1,CD300a molecule,CMRF35-like molecule 8; CD300 antigen-like family member A; CD300a antigen; CMRF35H leukocyte immunoglobulin-like receptor; NK inhibitory receptor; immunoglobulin superfamily member 12; inhibitory receptor protein 60; leukocyte membrane antigen
CD300c,CD300C,10871,LIR CLM-6 CMRF35 IGSF16 CMRF-35 CMRF35A CMRF-35A CMRF35A1 CMRF35-A1LIR CLM-6 CMRF35 IGSF16 CMRF-35 CMRF35A CMRF-35A CMRF35A1 CMRF35-A1,CD300c molecule,17q25.1,-
CD301,CLEC10A,10462,CD301 CLECSF13 CLECSF14 HML HML2 MGL,17p13.1,C-type lectin domain family 10 member A,"C-type lectin domain family 10 member A; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 13 (macrophage-derived); C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 14 (macrophage-derived); macrophage lectin 2 (calcium dependent)"
CD302,CD302,9936,BIMLEC CLEC13A DCL-1 DCL1,2q24.2,CD302 molecule,"CD302 antigen; C-type lectin domain family 13, member A; DEC205-associated C-type lectin 1; type I transmembrane C-type lectin receptor DCL-1"
CD303,CLEC4C,170482,BDCA2 CD303 CLECSF11 CLECSF7 DLEC HECL PRO34150,12p13.31,C-type lectin domain family 4 member C,"C-type lectin domain family 4 member C; BDCA-2; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 11; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 7; C-type lectin domain family 4, member C; C-type lectin superfamily member 7; blood dendritic cell antigen 2 protein; dendritic cell lectin b; dendritic lectin"
CD304,NRP1,8829,BDCA4 CD304 NP1 NRP VEGF165R,10p11.22,neuropilin 1,neuropilin-1; transmembrane receptor; vascular endothelial cell growth factor 165 receptor
CD305,LAIR1,3903,CD305 LAIR-1,19q13.42,leukocyte associated immunoglobulin like receptor 1,leukocyte-associated immunoglobulin-like receptor 1; immunoglobulin heavy chain variable region; leukocyte-associated Ig-like receptor 1
CD306,LAIR2,3904,CD306,19q13.42,leukocyte associated immunoglobulin like receptor 2,leukocyte-associated immunoglobulin-like receptor 2; LAIR-2; leukocyte-associated Ig-like receptor-2
CD307a,FCRL1,115350,CD307a FCRH1 IFGP1 IRTA5,1q23.1,Fc receptor like 1,"Fc receptor-like protein 1; IFGP family protein 1; fc receptor homolog 1; fcR-like protein 1; hIFGP1; immune receptor translocation-associated protein 5; immunoglobulin superfamily Fc receptor, gp42"
CD307b,FCRL2,79368,CD307b FCRH2 IFGP4 IRTA4 SPAP1 SPAP1A SPAP1B SPAP1C,1q23.1,Fc receptor like 2,"Fc receptor-like protein 2; IFGP family protein 4; SH2 domain containing phosphatase anchor protein 1; fc receptor homolog 2; immune receptor translocation-associated protein 4; immunoglobulin receptor translocation-associated protein 4; immunoglobulin superfamily Fc receptor, gp42"
CD307c,FCRL3,115352,CD307c FCRH3 IFGP3 IRTA3 SPAP2,1q23.1,Fc receptor like 3,Fc receptor-like protein 3; Fc receptor homolog 3; IFGP family protein 3; SH2 domain-containing phosphatase anchor protein 2; fcR-like protein 3; hIFGP3; immune receptor translocation-associated protein 3; immunoglobulin superfamily receptor translocation associated protein 3
CD307d,FCRL4,83417,CD307d FCRH4 IGFP2 IRTA1,1q23.1,Fc receptor like 4,"Fc receptor-like protein 4; IFGP family protein 2; fc receptor homolog 4; fcR-like protein 4; hIFGP2; immune receptor translocation-associated protein 1; immunoglobulin superfamily Fc receptor, gp42; immunoglobulin superfamily receptor translocation associated 1"
CD307e,FCRL5,83416,BXMAS1 CD307 CD307e FCRH5 IRTA2 PRO820,1q23.1,Fc receptor like 5,Fc receptor-like protein 5; fc receptor homolog 5; fcR-like protein 5; immune receptor translocation-associated protein 2; immunoglobulin superfamily receptor translocation associated 2 (IRTA2)
CD309,KDR,3791,CD309 FLK1 VEGFR VEGFR2,4q12,kinase insert domain receptor,vascular endothelial growth factor receptor 2; fetal liver kinase-1; kinase insert domain receptor (a type III receptor tyrosine kinase); protein-tyrosine kinase receptor Flk-1; soluble VEGFR2; tyrosine kinase growth factor receptor
CD312,ADGRE2,30817,CD312 EMR2 VBU,19p13.12,adhesion G protein-coupled receptor E2,"adhesion G protein-coupled receptor E2; EGF-like module-containing mucin-like hormone receptor-like 2; egf-like module containing, mucin-like, hormone receptor-like 2"
CD314,KLRK1,22914,CD314 D12S2489E KLR NKG2-D NKG2D,12p13.2,killer cell lectin like receptor K1,"NKG2-D type II integral membrane protein; NK cell receptor D; NKG2-D-activating NK receptor; killer cell lectin-like receptor subfamily K, member 1"
CD315,PTGFRN,5738,CD315 CD9P-1 EWI-F FPRP SMAP-6,1p13.1,prostaglandin F2 receptor inhibitor,prostaglandin F2 receptor negative regulator; CD9 partner 1; glu-Trp-Ile EWI motif-containing protein F; prostaglandin F2-alpha receptor regulatory protein; prostaglandin F2-alpha receptor-associated protein
CD316,IGSF8,93185,CD316 CD81P3 EWI-2 EWI2 KCT-4 LIR-D1 PGRL,1q23.2,immunoglobulin superfamily member 8,immunoglobulin superfamily member 8; CD81 partner 3; glu-Trp-Ile EWI motif-containing protein 2; keratinocytes-associated transmembrane protein 4; prostaglandin regulatory-like protein
CD317,BST2,684,CD317 TETHERIN,19p13.11,bone marrow stromal cell antigen 2,bone marrow stromal antigen 2; BST-2; HM1.24 antigen; NPC-A-7
CD318,CDCP1,64866,CD318 SIMA135 TRASK,3p21.31,CUB domain containing protein 1,CUB domain-containing protein 1; membrane glycoprotein gp140; subtractive immunization M plus HEp3-associated 135 kDa protein; transmembrane and associated with src kinases
CD319,SLAMF7,57823,19A CD319 CRACC CS1,1q23.3,SLAM family member 7,SLAM family member 7; 19A24 protein; CD2 subset 1; CD2-like receptor activating cytotoxic cells; membrane protein FOAP-12; novel LY9 (lymphocyte antigen 9) like protein; protein 19A
CD320,CD320,51293,8D6 8D6A TCBLR,19p13.2,CD320 molecule,CD320 antigen; 8D6 antigen; FDC-SM-8D6; FDC-signaling molecule 8D6; transcobalamin receptor
CD321,F11R,50848,CD321 JAM JAM1 JAMA JCAM KAT PAM-1,1q23.3,F11 receptor,junctional adhesion molecule A; junctional adhesion molecule 1; platelet F11 receptor; platelet adhesion molecule 1
CD322,JAM2,58494,C21orf43 CD322 JAM-B JAMB PRO245 VE-JAM VEJAM,21q21.3,junctional adhesion molecule 2,junctional adhesion molecule B; JAM-2; JAM-IT/VE-JAM; vascular endothelial junction-associated molecule
CD324,CDH1,999,Arc-1 CD324 CDHE ECAD LCAM UVO,16q22.1,cadherin 1,"cadherin-1; CAM 120/80; E-cadherin 1; cadherin 1, E-cadherin (epithelial); cadherin 1, type 1, E-cadherin (epithelial); calcium-dependent adhesion protein, epithelial; cell-CAM 120/80; epithelial cadherin; uvomorulin"
CD325,CDH2,1000,CD325 CDHN CDw325 NCAD,18q12.1,cadherin 2,"cadherin-2; N-cadherin 1; cadherin 2, type 1, N-cadherin (neuronal); calcium-dependent adhesion protein, neuronal; neural cadherin"
CD326,EPCAM,4072,DIAR5 EGP-2 EGP314 EGP40 ESA HNPCC8 KS1/4 KSA M4S1 MIC18 MK-1 TACSTD1 TROP1,2p21,epithelial cell adhesion molecule,"epithelial cell adhesion molecule; adenocarcinoma-associated antigen; cell surface glycoprotein Trop-1; epithelial glycoprotein 314; human epithelial glycoprotein-2; major gastrointestinal tumor-associated protein GA733-2; membrane component, chromosome 4, surface marker (35kD glycoprotein); tumor-associated calcium signal transducer 1"
CD327,SIGLEC6,946,CD327 CD33L CD33L1 CD33L2 CDW327 OBBP1,19q13.41,sialic acid binding Ig like lectin 6,sialic acid-binding Ig-like lectin 6; CD33 antigen-like 1; obesity-binding protein 1
CD328,SIGLEC7,27036,AIRM1 CD328 CDw328 D-siglec QA79 SIGLEC-7 SIGLEC19P SIGLECP2 p75 p75/AIRM1,19q13.41,sialic acid binding Ig like lectin 7,"sialic acid-binding Ig-like lectin 7; AIRM-1; QA79 membrane protein; adhesion inhibitory receptor molecule 1, siglec-7; sialic acid binding immunoglobulin-like lectin 7"
CD329,SIGLEC9,27180,CD329 CDw329 FOAP-9 OBBP-LIKE siglec-9,19q13.41,sialic acid binding Ig like lectin 9,sialic acid-binding Ig-like lectin 9; protein FOAP-9
CD331,FGFR1,2260,BFGFR CD331 CEK ECCL FGFBR FGFR-1 FLG FLT-2 FLT2 HBGFR HH2 HRTFDS KAL2 N-SAM OGD bFGF-R-1,8p11.23,fibroblast growth factor receptor 1,fibroblast growth factor receptor 1; FGFR1/PLAG1 fusion; FMS-like tyrosine kinase 2; basic fibroblast growth factor receptor 1; fms-related tyrosine kinase 2; heparin-binding growth factor receptor; hydroxyaryl-protein kinase; proto-oncogene c-Fgr
CD332,FGFR2,2263,BBDS BEK BFR-1 CD332 CEK3 CFD1 ECT1 JWS K-SAM KGFR TK14 TK25,10q26.13,fibroblast growth factor receptor 2,"fibroblast growth factor receptor 2; BEK fibroblast growth factor receptor; bacteria-expressed kinase; keratinocyte growth factor receptor; protein tyrosine kinase, receptor like 14"
CD333,FGFR3,2261,ACH CD333 CEK2 HSFGFR3EX JTK4,4p16.3,fibroblast growth factor receptor 3,fibroblast growth factor receptor 3; FGFR-3; fibroblast growth factor receptor 3 variant 4; hydroxyaryl-protein kinase; tyrosine kinase JTK4
CD334,FGFR4,2264,CD334 JTK2 TKF,5q35.2,fibroblast growth factor receptor 4,fibroblast growth factor receptor 4; hydroxyaryl-protein kinase; protein-tyrosine kinase; tyrosine kinase related to fibroblast growth factor receptor; tyrosylprotein kinase
CD335,NCR1,9437,CD335 LY94 NK-p46 NKP46,19q13.42,natural cytotoxicity triggering receptor 1,natural cytotoxicity triggering receptor 1; NK cell-activating receptor; lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46); natural killer cell p46-related protein
CD336,NCR2,9436,CD336 LY95 NK-p44 NKP44 dJ149M18.1,6p21.1,natural cytotoxicity triggering receptor 2,natural cytotoxicity triggering receptor 2; NK cell activating receptor (NKp44); NK cell-activating receptor; lymphocyte antigen 95 (activating NK-receptor; NK-p44); lymphocyte antigen 95 homolog (activating NK-receptor; NK-p44); natural killer cell p44-related protein
CD337,NCR3,259197,1C7 CD337 LY117 MALS NKp30,6p21.33,natural cytotoxicity triggering receptor 3,natural cytotoxicity triggering receptor 3; NK-p30; activating NK-A1 receptor; activating natural killer receptor p30; lymphocyte antigen 117; natural killer cell p30-related protein
CD338,ABCG2,9429,ABC15 ABCP BCRP BCRP1 BMDP CD338 CDw338 EST157481 GOUT1 MRX MXR MXR-1 MXR1 UAQTL1,4q22.1,ATP binding cassette subfamily G member 2 (Junior blood group),"ATP-binding cassette sub-family G member 2; ABC transporter; ATP-binding cassette transporter G2; ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group); breast cancer resistance protein; mitoxantrone resistance-associated protein; multi drug resistance efflux transport ATP-binding cassette sub-family G (WHITE) member 2; placenta specific MDR protein; placenta-specific ATP-binding cassette transporter; urate exporter"
CD339,JAG1,182,AGS AGS1 AHD AWS CD339 HJ1 JAGL1,20p12.2,jagged 1,protein jagged-1
CD340,ERBB2,2064,CD340 HER-2 HER-2/neu HER2 MLN 19 NEU NGL TKR1,17q12,erb-b2 receptor tyrosine kinase 2,"receptor tyrosine-protein kinase erbB-2; c-erb B2/neu protein; herstatin; human epidermal growth factor receptor 2; metastatic lymph node gene 19 protein; neuro/glioblastoma derived oncogene homolog; neuroblastoma/glioblastoma derived oncogene homolog; p185erbB2; proto-oncogene Neu; proto-oncogene c-ErbB-2; tyrosine kinase-type cell surface receptor HER2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog"
CD344,FZD4,8322,CD344 EVR1 FEVR FZD4S Fz-4 Fz4 FzE4 GPCR hFz4,11q14.2,frizzled class receptor 4,"frizzled-4; WNT receptor frizzled-4; frizzled 4, seven transmembrane spanning receptor; frizzled family receptor 4; frizzled homolog 4"
CD349,FZD9,8326,CD349 FZD3,7q11.23,frizzled class receptor 9,"frizzled-9; frizzled 9, seven transmembrane spanning receptor; frizzled family receptor 9; frizzled homolog 9; fz-9; fzE6; hFz9"
CD350,FZD10,11211,CD350 FZ-10 Fz10 FzE7 hFz10,12q24.33,frizzled class receptor 10,"frizzled-10; frizzled 10, seven transmembrane spanning receptor; frizzled family receptor 10; frizzled homolog 10"
CD351,FCAMR,83953,CD351 FCA/MR FKSG87,1q32.1,Fc fragment of IgA and IgM receptor,"high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor; Fc alpha/mu receptor; Fc receptor, IgA, IgM, high affinity; immunity related factor; receptor for Fc fragment of IgA and IgM"
CD352,SLAMF6,114836,CD352 KALI KALIb Ly108 NTB-A NTBA SF2000,1q23.2-q23.3,SLAM family member 6,"SLAM family member 6; NK-T-B-antigen; NTBA receptor; activating NK receptor; natural killer-, T- and B-cell antigen"
CD353,SLAMF8,56833,BLAME CD353 SBBI42,1q23.2,SLAM family member 8,SLAM family member 8; B lymphocyte activator macrophage expressed; BCM-like membrane protein
CD354,TREM1,54210,CD354 TREM-1,6p21.1,triggering receptor expressed on myeloid cells 1,triggering receptor expressed on myeloid cells 1; triggering receptor expressed on monocytes 1
CD355,CRTAM,56253,CD355,11q24.1,cytotoxic and regulatory T-cell molecule,cytotoxic and regulatory T-cell molecule; class-I MHC-restricted T-cell-associated molecule
CD357,TNFRSF18,8784,AITR CD357 GITR GITR-D,1p36.33,TNF receptor superfamily member 18,tumor necrosis factor receptor superfamily member 18; TNF receptor superfamily activation-inducible protein; activation-inducible TNFR family receptor; glucocorticoid-induced TNFR-related protein
CD358,TNFRSF21,27242,BM-018 CD358 DR6,6p12.3,TNF receptor superfamily member 21,tumor necrosis factor receptor superfamily member 21; TNFR-related death receptor 6; death receptor 6
CD360,IL21R,50615,CD360 NILR,16p12.1,interleukin 21 receptor,interleukin-21 receptor; IL-21 receptor; novel interleukin receptor
CD361,EVI2B,2124,CD361 D17S376 EVDB,17q11.2,ecotropic viral integration site 2B,protein EVI2B; EVI-2B; ecotropic viral integration site 2B protein homolog
CD362,SDC2,6383,CD362 HSPG HSPG1 SYND2,8q22.1,syndecan 2,"syndecan-2; cell surface-associated heparan sulfate proteoglycan 1; fibroglycan; heparan sulfate proteoglycan 1, cell surface-associated; heparan sulfate proteoglycan core protein; syndecan proteoglycan 2"
CD363,S1PR1,1901,CD363 CHEDG1 D1S3362 ECGF1 EDG-1 EDG1 S1P1,1p21.2,sphingosine-1-phosphate receptor 1,"sphingosine 1-phosphate receptor 1; S1P receptor 1; S1P receptor Edg-1; endothelial differentiation G-protein coupled receptor 1; endothelial differentiation, sphingolipid G-protein-coupled receptor, 1; sphingosine 1-phosphate receptor EDG1; sphingosine 1-phosphate receptor Edg-1"
CD364,PI16,221476,CD364 CRISP9 MSMBBP PSPBP,6p21.2,peptidase inhibitor 16,"peptidase inhibitor 16; PSP94-binding protein; cysteine-rich secretory protein 9; microseminoprotein, beta-binding protein; protease inhibitor 16"
CD365,HAVCR1,26762,CD365 HAVCR HAVCR-1 KIM-1 KIM1 TIM TIM-1 TIM1 TIMD-1 TIMD1,5q33.3,hepatitis A virus cellular receptor 1,hepatitis A virus cellular receptor 1; T cell immunoglobin domain and mucin domain protein 1; T-cell immunoglobulin mucin family member 1; T-cell immunoglobulin mucin receptor 1; T-cell membrane protein 1; kidney injury molecule 1
CD366,HAVCR2,84868,CD366 HAVcr-2 KIM-3 TIM3 TIMD-3 TIMD3 Tim-3,5q33.3,hepatitis A virus cellular receptor 2,hepatitis A virus cellular receptor 2; T cell immunoglobulin mucin 3; T-cell immunoglobulin and mucin domain-containing protein 3; T-cell immunoglobulin mucin family member 3; T-cell immunoglobulin mucin receptor 3; T-cell membrane protein 3; kidney injury molecule-3
CD367,CLEC4A,50856,CD367 CLECSF6 DCIR DDB27 HDCGC13P LLIR,12p13.31,C-type lectin domain family 4 member A,"C-type lectin domain family 4 member A; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 6; C-type lectin DDB27; C-type lectin superfamily member 6; dendritic cell immunoreceptor; lectin-like immunoreceptor"
CD368,CLEC4D,338339,CD368 CLEC-6 CLEC6 CLECSF8 MCL MPCL,12p13.31,C-type lectin domain family 4 member D,"C-type lectin domain family 4 member D; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 8; C-type lectin receptor; C-type lectin superfamily member 8; C-type lectin-like receptor 6; macrophage C-type lectin"
CD369,CLEC7A,64581,BGR CANDF4 CD369 CLECSF12 DECTIN1 SCARE2,12p13.2,C-type lectin domain family 7 member A,"C-type lectin domain family 7 member A; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 12; C-type lectin superfamily member 12; DC-associated C-type lectin 1; beta-glucan receptor; dectin-1; dendritic cell-associated C-type lectin-1; lectin-like receptor 1"
CD370,CLEC9A,283420,CD370 DNGR-1 DNGR1 UNQ9341,12p13.2,C-type lectin domain family 9 member A,C-type lectin domain family 9 member A; HEEE9341
CD371,CLEC12A,160364,CD371 CLL-1 CLL1 DCAL-2 MICL,12p13.31,C-type lectin domain family 12 member A,C-type lectin domain family 12 member A; C-type lectin protein CLL-1; C-type lectin-like molecule-1; dendritic cell-associated lectin 2; myeloid inhibitory C-type lectin-like receptor
